{"content":"<li class=\"n-box-item date-title\" data-end=\"1544849999\" data-start=\"1544763600\" data-txt=\"Monday, December 23, 2019\">Friday, December 14, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3417320\" data-ts=\"1544827469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRIV\" target=\"_blank\">YRIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417320-stor-res-and-kdmn-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">STOR, RES and KDMN among after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a> <font color=\"green\">+12.1%</font>. <a href='https://seekingalpha.com/symbol/RES' title='RPC Inc.'>RES</a> <font color=\"green\">+7.4%</font>. <a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a> <font color=\"green\">+4.5%</font>. <a href='https://seekingalpha.com/symbol/TLK' title='P.T. Telekomunikasi Indonesia'>TLK</a> <font color=\"green\">+4.4%</font>. <a href='https://seekingalpha.com/symbol/SURF' title='Surface Oncology'>SURF</a> <font color=\"green\">+3.6%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/KDMN' title='Kadmon Holdings'>KDMN</a> <font color=\"red\">-2.8%</font>. <a href='https://seekingalpha.com/symbol/STOR' title='STORE Capital'>STOR</a> <font color=\"red\">-2.6%</font>. <a href='https://seekingalpha.com/symbol/PLYA' title='Playa Hotels & Resorts'>PLYA</a> <font color=\"red\">-2.4%</font>. <a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials'>SUM</a> <font color=\"red\">-1.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417320\" data-linked=\"STOR, RES and KDMN among after hour movers\" data-tweet=\"$YRIV $YRIV $RES - STOR, RES and KDMN among after hour movers https://seekingalpha.com/news/3417320-stor-res-and-kdmn-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3417320-stor-res-and-kdmn-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417316\" data-ts=\"1544826863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417316-catalyst-pharmaplus-3_4-director-buys-20000-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma +3.4% as director buys 20,000 shares</a></h4><ul>   <li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) is <font color=\"green\">up 3.4%</font> postmarket, after the disclosure that director Charles O'Keeffe <a href=\"https://seekingalpha.com/filing/4271251\" target=\"_blank\">bought 20,000 shares</a> today.</li>    <li>O'Keeffe got the shares at an average price of $2.50, for an outlay of about $50,000.</li>    <li>Following the transaction, his holdings sit at 543,376 shares.</li>    <li>Shares <font color=\"red\">fell 4.9%</font> during the regular session, on heavy volume today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417316\" data-linked=\"Catalyst Pharma +3.4% as director buys 20,000 shares\" data-tweet=\"$CPRX - Catalyst Pharma +3.4% as director buys 20,000 shares https://seekingalpha.com/news/3417316-catalyst-pharmaplus-3_4-director-buys-20000-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3417316-catalyst-pharmaplus-3_4-director-buys-20000-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417277\" data-ts=\"1544821884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUPN\" target=\"_blank\">SUPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417277-fda-oks-supernus-pharmas-oxtellar-xr-monotherapy-for-partial-onset-seizures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Supernus Pharma&#39;s Oxtellar XR as monotherapy for partial-onset seizures</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17359081-supernus-announces-fda-approval-snda-expand-oxtellar-xr-label-include-monotherapy\" target=\"_blank\">approves </a>Supernus Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/SUPN' title='Supernus Pharmaceuticals, Inc.'>SUPN</a>) marketing application to use Oxtellar XR (oxcarbazepine) extended-release tablets as monotherapy to treat partial-onset seizures in patients at least six years old.</li><li>Previously, the epilepsy med was approved as adjunctive treatment for partial-onset seizures in patients at least six years old.</li><li>Market launch for the new indication will commence next quarter.</li><li>Shares are up a fraction after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417277\" data-linked=\"FDA OKs Supernus Pharma&#39;s Oxtellar XR as monotherapy for partial-onset seizures\" data-tweet=\"$SUPN - FDA OKs Supernus Pharma&#39;s Oxtellar XR as monotherapy for partial-onset seizures https://seekingalpha.com/news/3417277-fda-oks-supernus-pharmas-oxtellar-xr-monotherapy-for-partial-onset-seizures?source=tweet\" data-url=\"https://seekingalpha.com/news/3417277-fda-oks-supernus-pharmas-oxtellar-xr-monotherapy-for-partial-onset-seizures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417265\" data-ts=\"1544820593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417265-crude-oil-settles-sharply-lower-after-weak-china-data-stronger-dollar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil settles sharply lower after weak China data, stronger dollar</a></h4><ul><li><a href=\"https://www.marketwatch.com/story/oil-falls-as-stock-weakness-and-dollar-strength-dull-impact-of-bullish-supply-data-2018-12-14\" target=\"_blank\">Crude oil prices tumbled</a> to wipe out the week's prior gains, weighed by a big drop in equities that followed weaker than expected data on China's economic growth as well as a stronger dollar; U.S. WTI settled <font color=\"red\">-2.6%</font> to $51.20/bbl, Brent <font color=\"red\">-2.1%</font> to $60.12/bbl.</li><li>\"For the time being until the OPEC cuts start kicking in, the market is  <a href=\"https://www.cnbc.com/2018/12/14/oil-prices-fall-as-investors-take-profits-amid-china-economy-worries.html\" target=\"_blank\">oversupplied in the short term</a>,\" says Mitsubishi oil risk manager Tony Nunan, adding \"if China is slowing down, that's definitely a  concern.\"</li><li>A stronger U.S. dollar plus volatile equity markets have weighed down crude, says Giovanni Staunovo, commodities analyst at UBS Wealth Management, but overall \"I would think oil prices are in a position of <a href=\"https://www.wsj.com/articles/oil-prices-follow-equities-lower-as-dollar-climbs-11544786979\" target=\"_blank\">stabilizing around this level</a>,\" aided by planned production curbs from OPEC and Russia.</li><li>Also, January natural gas futures settled <font color=\"red\">-7.2%</font> to $3.827/MMBtu, suffering its largest weekly drop (<font color=\"red\">-14.7%</font>) for a front month since January 2016.</li><li>The \"outlook for warmer-than-normal to normal weather through the end of the month\" weighed on prices, says James Williams of WTRG Economics. \"That, coupled with record high production of gas are the main reasons, despite very low levels of gas in storage for this time of year.\"</li><li>Oil and gas names are broadly lower: <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color=\"red\">-2.3%</font>, <a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color=\"red\">-2.2%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color=\"red\">-2.5%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"red\">-9.5%</font>, <a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color=\"red\">-8.8%</font>, <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color=\"red\">-8.1%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"red\">-3.7%</font>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color=\"red\">-3.9%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"red\">-3.4%</font>, <a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a> <font color=\"red\">-5%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"red\">-3.1%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"red\">-4.2%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"red\">-4.3%</font>, <a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color=\"red\">-2.3%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color=\"red\">-5.1%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"red\">-3.3%</font>, <a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color=\"red\">-2.7%</font>, <a href='https://seekingalpha.com/symbol/CVRR' title='CVR Refining, LP'>CVRR</a> <font color=\"red\">-10%</font>, <a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a> <font color=\"red\">-9.5%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color=\"red\">-7%</font>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color=\"red\">-8%</font>, <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"red\">-6.8%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3417265\" data-linked=\"Crude oil settles sharply lower after weak China data, stronger dollar\" data-tweet=\"$XOM $XOM $CVX - Crude oil settles sharply lower after weak China data, stronger dollar https://seekingalpha.com/news/3417265-crude-oil-settles-sharply-lower-after-weak-china-data-stronger-dollar?source=tweet\" data-url=\"https://seekingalpha.com/news/3417265-crude-oil-settles-sharply-lower-after-weak-china-data-stronger-dollar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>131&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417264\" data-ts=\"1544820521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BT\" target=\"_blank\">BT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417264-uk-telecoms-face-price-transparency-push-from-regulators\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UK telecoms face price-transparency push from regulators</a></h4><ul>   <li>Some UK-facing telecoms have moved today after the country's regulators look to <a href=\"http://www.gizmodo.co.uk/2018/12/ofcom-end-of-contract-notifications/\" target=\"_blank\">force price transparency measures</a> that could crimp earnings the companies see from unaware consumers.</li>    <li>Regulator Ofcom plans to force all electronic communications services -- Internet, pay TV and phone -- to alert customers to their best available prices as contracts end, and each year after that.</li>    <li>\"We want people to be able to take advantage of the wide choice of communication services available and shop around with confidence, so that at the end of their fixed commitment period they can get the best deals for their needs,\" Ofcom says. \"This could mean taking up a new deal with their current provider, or switching to a new supplier.\"</li>    <li>At incumbent telecom <a href='https://seekingalpha.com/symbol/BT' title='BT Group plc'>BT</a>, there could be a 40% difference between new and historical prices, Barclays notes -- which creates an annual earnings exposure of up to £500M. (h/t Bloomberg)</li>    <li><a href='https://seekingalpha.com/symbol/BT' title='BT Group plc'>BT</a> is <font color=\"red\">down 0.8%</font> in U.S. trading. Other affected companies: <a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a>; <a href='https://seekingalpha.com/symbol/LBTYA' title='Liberty Global, Inc.'>LBTYA</a> <font color=\"red\">-2.3%</font>; <a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a> <font color=\"red\">-1.3%</font>; <a href='https://seekingalpha.com/symbol/TKTCY' title='Talktalk Telecom Group, PLC ADR'>OTCPK:TKTCY</a>; <a href='https://seekingalpha.com/symbol/CKHUY' title='CK Hutchison Holdings LTD ADR'>OTCPK:CKHUY</a> <font color=\"green\">+1%</font>; <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color=\"red\">-1.3%</font> (via Sky).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417264\" data-linked=\"UK telecoms face price-transparency push from regulators\" data-tweet=\"$BT $BT $VOD - UK telecoms face price-transparency push from regulators https://seekingalpha.com/news/3417264-uk-telecoms-face-price-transparency-push-from-regulators?source=tweet\" data-url=\"https://seekingalpha.com/news/3417264-uk-telecoms-face-price-transparency-push-from-regulators\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417263\" data-ts=\"1544820520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417263-thoma-bravo-buy-mcafee-for-over-4_2b-symcminus-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thoma Bravo could buy McAfee for over $4.2B; SYMC -4%</a></h4><ul><li>Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-0.7%</font>) and TPG are in early talks to sell McAfee to private equity firm Thoma Bravo for \"significantly\" more than $4.2B, according to <a href=\"https://www.cnbc.com/2018/12/14/intel-tpg-in-talks-to-sell-mcafee-to-thoma-bravo.html\" target=\"_blank\">CNBC sources</a>.</li><li>Intel bought McAfee for $7.6B in 2010.</li><li>TPG acquired a stake in McAfee in 2006 that valued the cybersecurity company at $4.2B. TPG later brought Thoma Bravo in as a minority investor.</li><li>Deal talks could change or fall apart. Sources say that if Thoma Bravo does buy McAfee, it will back away from a Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) purchase.</li><li>SYMC is <font color=\"red\">down 4.1% </font>to $21.55.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417263\" data-linked=\"Thoma Bravo could buy McAfee for over $4.2B; SYMC -4%\" data-tweet=\"$INTC $INTC $NLOK - Thoma Bravo could buy McAfee for over $4.2B; SYMC -4% https://seekingalpha.com/news/3417263-thoma-bravo-buy-mcafee-for-over-4_2b-symcminus-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3417263-thoma-bravo-buy-mcafee-for-over-4_2b-symcminus-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417259\" data-ts=\"1544819187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUN\" target=\"_blank\">RUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417259-sunrunminus-10-on-fbi-investigation-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunrun -10% on FBI investigation report</a></h4><ul><li>Sunrun (NASDAQ:<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a>) <font color=\"red\">plunges 10.7%</font> on a Seeking Alpha article detailing a previously undisclosed FBI and Justice Department investigation for fraud that runs parallel to the SEC investigation.</li><li>The information came to light through a Freedom of Information Act request.</li><li>Read Investor Gator's full rundown <a href=\"https://seekingalpha.com/article/4228435-sunrun-subject-undisclosed-fraud-investigation-fbi-justice-department\" target=\"_blank\">here</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417259\" data-linked=\"Sunrun -10% on FBI investigation report\" data-tweet=\"$RUN - Sunrun -10% on FBI investigation report https://seekingalpha.com/news/3417259-sunrunminus-10-on-fbi-investigation-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3417259-sunrunminus-10-on-fbi-investigation-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417257\" data-ts=\"1544818872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSX\" target=\"_blank\">PSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417257-phillips-66-unveils-2_3b-capital-spending-program-for-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phillips 66 unveils $2.3B capital spending program for 2019</a></h4><ul><li>Phillips 66 (<a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color='red'>-2.4%</font>) announces a <a href=\"https://seekingalpha.com/pr/17359027-phillips-66-announces-2019-capital-program\" target=\"_blank\">$2.3B capex budget</a> for 2019 and reiterates its long-term objective to reinvest 60% of cash flow into the business and return 40% to shareholders through dividends and buybacks.</li><li>PSX says it plans $1.6B in capex at its Midstream segment, including $601M million for Phillips 66 Partners (<a href='https://seekingalpha.com/symbol/PSXP' title='Phillips 66 Partners LP'>PSXP</a> <font color='green'>+0.7%</font>), and reflects       expected joint venture-level financing to fund part of the Gray Oak       Pipeline construction.</li><li>PSX also plans $923M of capital spending in its refining business and $161M in the Marketing and Specialties segment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417257\" data-linked=\"Phillips 66 unveils $2.3B capital spending program for 2019\" data-tweet=\"$PSX $PSX $PSXP - Phillips 66 unveils $2.3B capital spending program for 2019 https://seekingalpha.com/news/3417257-phillips-66-unveils-2_3b-capital-spending-program-for-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3417257-phillips-66-unveils-2_3b-capital-spending-program-for-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417255\" data-ts=\"1544818017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417255-telecom-italia-receives-request-from-vivendi-for-shareholder-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Italia receives request from Vivendi for shareholder meeting</a></h4><ul>   <li>Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color=\"red\">-2.2%</font>) has confirmed that it's gotten a <a href=\"https://www.businesswire.com/news/home/20181214005473/en/Vivendi-Update-Letter-Telecom-Italia\" target=\"_blank\">formal request from Vivendi</a> (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color=\"red\">-1.6%</font>), its largest shareholder, to convene a shareholders' meeting as part of Vivendi's wrestling match with Elliott Management.</li>    <li>Vivendi's proposed agenda includes revoking five directors (Fulvio Conti, Alfredo Altavilla, Massimo Ferrari, Dante Roscini and Paola Giannotti de Ponti) and appointing its chosen replacements (Franco Bernabè, Rob van der Valk, Flavia Mazzarella, Gabriele Galateri di Genola and Francesco Vatalaro).</li>    <li>Vivendi \"asked that the agenda of the Shareholders\u2019 Meeting includes a vote on the revocation of five Board members from the Elliott list who showed a substantial lack of independence and disrespect for the most basic and fundamental corporate governance rules, negatively affecting the organization and image of Telecom Italia,\" it says.</li>    <li>It's also asking for new financial auditors.</li>    <li>Vivendi lost control of the company to Elliott last May in a board shift.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417255\" data-linked=\"Telecom Italia receives request from Vivendi for shareholder meeting\" data-tweet=\"$TI $TI $VIVHY - Telecom Italia receives request from Vivendi for shareholder meeting https://seekingalpha.com/news/3417255-telecom-italia-receives-request-from-vivendi-for-shareholder-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3417255-telecom-italia-receives-request-from-vivendi-for-shareholder-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417253\" data-ts=\"1544817606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRAD\" target=\"_blank\">LRAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417253-microcaps-mostly-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among tech movers</a></h4><ul><li><strong>Gainers: </strong>LRAD Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/LRAD' title='LRAD Corp'>LRAD</a>) <font color=\"green\">+13%</font>. Fusion Connect (NASDAQ:<a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a>) <font color=\"green\">+11%</font>. Materialise NV (NASDAQ:<a href='https://seekingalpha.com/symbol/MTLS' title='Materialise NV'>MTLS</a>) <font color=\"green\">+7%</font>. Aware (NASDAQ:<a href='https://seekingalpha.com/symbol/AWRE' title='Aware, Inc.'>AWRE</a>) <font color=\"green\">+6%</font>. Resonant (NASDAQ:<a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a>) <font color=\"green\">+6%</font>.</li> <li><strong>Losers: </strong>One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"red\">-17%</font>. Intermolecular (NASDAQ:<a href='https://seekingalpha.com/symbol/IMI' title='Intermolecular, Inc.'>IMI</a>) <font color=\"red\">-13%</font>. Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a>) <font color=\"red\">-12%</font>. CSP (NASDAQ:<a href='https://seekingalpha.com/symbol/CSPI' title='CSP Inc.'>CSPI</a>) <font color=\"red\">-12%</font>. nLIGHT (NASDAQ:<a href='https://seekingalpha.com/symbol/LASR' title='nLIGHT, Inc.'>LASR</a>) <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417253\" data-linked=\"Microcaps mostly among tech movers\" data-tweet=\"$LRAD $GNSS $FSNN - Microcaps mostly among tech movers https://seekingalpha.com/news/3417253-microcaps-mostly-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3417253-microcaps-mostly-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417252\" data-ts=\"1544817405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417252-wsj-u-k-s-serious-fraud-office-investigates-acacia-mining\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: U.K.&#39;s Serious Fraud Office investigates Acacia Mining</a></h4><ul><li>The U.K.\u2019s Serious Fraud Office is <a href=\"https://www.wsj.com/articles/britains-fraud-office-investigates-acacia-mining-11544809237\" target=\"_blank\">investigating</a> Barrick Gold (ABX <font color='red'>-2.8%</font>) subsidiary Acacia Mining (<a href='https://seekingalpha.com/symbol/ABGLF' title='Acacia Mining PLC'>OTCPK:ABGLF</a>) over allegations of corruption in Tanzania, <em>WSJ</em> reports.</li><li>The British probe into Acacia focuses around accusations that employees of the company, which was called African Barrick until 2014, bribed Tanzanian government officials and consultants, according to the report.</li><li>Acacia also is being investigated by Tanzanian officials over corruption allegations, and the interest of U.K. law enforcement marks a new level of scrutiny over the company and another headache for ABX.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417252\" data-linked=\"WSJ: U.K.&#39;s Serious Fraud Office investigates Acacia Mining\" data-tweet=\"$GOLD $GOLD $ABGLF - WSJ: U.K.&#39;s Serious Fraud Office investigates Acacia Mining https://seekingalpha.com/news/3417252-wsj-u-k-s-serious-fraud-office-investigates-acacia-mining?source=tweet\" data-url=\"https://seekingalpha.com/news/3417252-wsj-u-k-s-serious-fraud-office-investigates-acacia-mining\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417249\" data-ts=\"1544816241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCG\" target=\"_blank\">SCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417249-scanaplus-6-state-regulators-say-will-support-dominion-takeover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SCANA +6% as state regulators say they will support Dominion takeover</a></h4><ul><li>SCANA (<a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='green'>+6.6%</font>) soars to a 52-week high after a majority of South Carolina regulators indicate they <a href=\"https://finance.yahoo.com/news/latest-state-regulators-support-15b-utility-merger-185811254.html\" target=\"_blank\">will vote to approve</a> the company's acquisition by Dominion Energy (<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a> <font color='green'>+1.4%</font>).</li><li>At least five of the seven members of the state's Public Service Commission said ahead of this afternoon's vote that they would support the deal to buy the parent company of South Carolina Electric &amp; Gas.</li><li>The PSC also will decide how much to cut rates for 737K SCE&amp;G customers who already have paid $2B-plus related to the abandoned V.C. Summer nuclear reactor projected.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417249\" data-linked=\"SCANA +6% as state regulators say they will support Dominion takeover\" data-tweet=\"$SCG $SCG $D - SCANA +6% as state regulators say they will support Dominion takeover https://seekingalpha.com/news/3417249-scanaplus-6-state-regulators-say-will-support-dominion-takeover?source=tweet\" data-url=\"https://seekingalpha.com/news/3417249-scanaplus-6-state-regulators-say-will-support-dominion-takeover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417248\" data-ts=\"1544815830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417248-j-and-j-reuters-story-false\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J: Reuters story &#39;false&#39;</a></h4><ul><li>\"The Reuters article is one-sided, false, and inflammatory,\" says the company. \"Johnson &amp; Johnson's (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-9.4%</font>) baby powder is safe and asbestos-free.\"</li><li>J&amp;J notes studies of more than 100K people show talc doesn't cause cancer or asbestos-related disease.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17358994-statement-reuters-talc-article\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3417132-johnson-and-johnson-4-percent-reports-prior-knowledge-asbestos-baby-powder\" target=\"_blank\">Johnson &amp; Johnson down 4% on reports of prior knowledge of asbestos in baby powder</a> (Dec. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417248\" data-linked=\"J&amp;J: Reuters story &#39;false&#39;\" data-tweet=\"$JNJ - J&amp;J: Reuters story &#39;false&#39; https://seekingalpha.com/news/3417248-j-and-j-reuters-story-false?source=tweet\" data-url=\"https://seekingalpha.com/news/3417248-j-and-j-reuters-story-false\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>176&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417246\" data-ts=\"1544815514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRCW\" target=\"_blank\">YRCW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417246-yrc-worldwideminus-20-after-doj-alleges-systematic-overcharging-of-shipments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YRC Worldwide -20% after DoJ alleges &#39;systematic overcharging&#39; of shipments</a></h4><ul><li>YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color=\"red\">-20.5%</font>) sinks to a 52-week low after the U.S. Department of Justice <a href=\"https://www.justice.gov/opa/pr/united-states-sues-freight-companies-systematic-overcharging-shipments\" target=\"_blank\">files a lawsuit</a> against some of the company's units alleging the freight companies \"systematically overcharged\" the federal government for freight carrier services and made false statements to hide their misconduct.</li><li>The lawsuit filed in the U.S. District Court in Buffalo alleges that for more than seven years the subsidiaries defrauded the Defense Department \"by millions of dollars for shipments that were actually lighter, and thus cheaper, than the weights for which the defendants charged the government.\"</li><li>YRCW says the government's claims are \"<a href=\"https://seekingalpha.com/pr/17359018-yrc-freight-statement-u-s-government-litigation\" target=\"_blank\">totally without merit</a>.\"</li><li>Other freight companies also trade lower: <a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color=\"red\">-2.9%</font>, <a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color=\"red\">-2.2%</font>, <a href='https://seekingalpha.com/symbol/ODFL' title='Old Dominion Freight Line, Inc.'>ODFL</a> <font color=\"red\">-1.2%</font>, <a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a> <font color=\"red\">-1.2%</font>, <a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a> <font color=\"red\">-0.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417246\" data-linked=\"YRC Worldwide -20% after DoJ alleges &#39;systematic overcharging&#39; of shipments\" data-tweet=\"$YRCW $YRCW $JBHT - YRC Worldwide -20% after DoJ alleges &#39;systematic overcharging&#39; of shipments https://seekingalpha.com/news/3417246-yrc-worldwideminus-20-after-doj-alleges-systematic-overcharging-of-shipments?source=tweet\" data-url=\"https://seekingalpha.com/news/3417246-yrc-worldwideminus-20-after-doj-alleges-systematic-overcharging-of-shipments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417245\" data-ts=\"1544814965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417245-reuters-t-mobile-sprint-expect-cfius-clearance-drop-huawei\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: T-Mobile/Sprint expect CFIUS clearance, if they drop Huawei</a></h4><ul>   <li>T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-1.2%</font>) and Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-1.3%</font>) now expect their proposed merger to get <a href=\"https://www.reuters.com/article/us-sprint-corp-m-a-t-mobile-huawei-exclu/exclusive-t-mobile-sprint-consider-dropping-huawei-see-u-s-security-clearance-for-deal-sources-idUSKBN1OD2HO\" target=\"_blank\">U.S. security clearance as soon as next week</a> after their parent companies said they'd consider dropping use of equipment from China's Huawei, Reuters reports.</li>    <li>The Committee on Foreign Investment in the United States is reviewing the deal between the two companies, owned respectively by Germany's Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color=\"red\">-0.4%</font>) and Japan's SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color=\"red\">-6.6%</font>).</li><li>And the U.S. is applying pressure to stop using equipment from Huawei over concerns about \"back doors\" that would enable espionage by China.</li>    <li>SoftBank plans to <a href=\"https://seekingalpha.com/news/3416641-softbank-next-replace-huawei-equipment\" target=\"_blank\">replace Huawei gear</a> with equipment from Ericsson (<a href=\"http://seekingalpha.com/symbol/ERIC\" target=\"_blank\">ERIC</a> <font color=\"red\">-1.5%</font>) and Nokia (<a href=\"http://seekingalpha.com/symbol/NOK\" target=\"_blank\">NOK</a> <font color=\"red\">-1.1%</font>), Nikkei reported.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417245\" data-linked=\"Reuters: T-Mobile/Sprint expect CFIUS clearance, if they drop Huawei\" data-tweet=\"$TMUS $TMUS $S - Reuters: T-Mobile/Sprint expect CFIUS clearance, if they drop Huawei https://seekingalpha.com/news/3417245-reuters-t-mobile-sprint-expect-cfius-clearance-drop-huawei?source=tweet\" data-url=\"https://seekingalpha.com/news/3417245-reuters-t-mobile-sprint-expect-cfius-clearance-drop-huawei\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417243\" data-ts=\"1544814062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417243-d-davidson-cuts-apple-target-says-pullback-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">D.A. Davidson cuts Apple target, says pullback overdone</a></h4><ul><li>D.A. Davidson <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Apple+%28AAPL%29+PT+Lowered+to+%24280+at+DA+Davidson%2C+Says+Buy+the+Pullback/14923719.html\" target=\"_blank\">maintains</a> a Buy rating on Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) but cuts the price target from $290 to $280.</li><li>Analyst Tom Forte cites near-term projections on lower than expected iPhone sales and reiterates that higher ASPs on the new iPhones could result in an upside to the firm's forecast.</li><li>Forte says that the recent pullback was overdone and that the lower near-term performance is already priced into shares.</li><li>Apple shares are <font color=\"red\">down 2.4%</font> to $166.79.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3417051-noted-analyst-cuts-iphone-estimates\" target=\"_blank\">Noted analyst cuts iPhone estimates</a> (Dec. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417243\" data-linked=\"D.A. Davidson cuts Apple target, says pullback overdone\" data-tweet=\"$AAPL - D.A. Davidson cuts Apple target, says pullback overdone https://seekingalpha.com/news/3417243-d-davidson-cuts-apple-target-says-pullback-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3417243-d-davidson-cuts-apple-target-says-pullback-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417242\" data-ts=\"1544814053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417242-wheaton-precious-metals-and-valhi-among-energy-materials-gainers-comstock-resources-and-new\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wheaton Precious Metals and Valhi among Energy/Materials gainers; Comstock Resources and New Concept Energy among losers</a></h4><ul><li><b>Gainers: </b>Wheaton Precious Metals (NYSE:<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a>) <font color=\"green\">+15%</font>. Valhi (NYSE:<a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a>) <font color=\"green\">+7%</font>. Tantech (NASDAQ:<a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a>) <font color=\"green\">+6%</font>. CONSOL Coal Resources (NYSE:<a href='https://seekingalpha.com/symbol/CCR' title='CONSOL Coal Resources LP'>CCR</a>) <font color=\"green\">+4%</font>.</li><li><b>Losers: </b>Comstock Resources (NYSE:<a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a>) <font color=\"red\">-15%</font>. New Concept Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a>) <font color=\"red\">-14%</font>. CVR Refining (NYSE:<a href='https://seekingalpha.com/symbol/CVRR' title='CVR Refining, LP'>CVRR</a>) <font color=\"red\">-13%</font>. Mexco Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a>) <font color=\"red\">-12%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417242\" data-linked=\"Wheaton Precious Metals and Valhi among Energy/Materials gainers; Comstock Resources and New Concept Energy among losers\" data-tweet=\"$WPM $WPM $VHI - Wheaton Precious Metals and Valhi among Energy/Materials gainers; Comstock Resources and New Concept Energy among losers https://seekingalpha.com/news/3417242-wheaton-precious-metals-and-valhi-among-energy-materials-gainers-comstock-resources-and-new?source=tweet\" data-url=\"https://seekingalpha.com/news/3417242-wheaton-precious-metals-and-valhi-among-energy-materials-gainers-comstock-resources-and-new\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417239\" data-ts=\"1544813643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417239-analysts-trim-adobe-targets-express-marketo-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts trim Adobe targets, express Marketo concerns</a></h4><ul><li>Pivotal Research <a href=\"https://www.cnbc.com/2018/12/14/adobe-trades-lower-after-q4-2018-beat.html\" target=\"_blank\">maintains </a>a Hold rating on Adobe (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) and lowers the target from $254 to $252 after earnings.</li><li>Analyst Brian Wieser: \"Revised 2019 guidance on first glance also had negative characteristics relative to our prior estimates and those of consensus, but on further review and with additional information from the company conveyed during the call, long-term trends appear to be on track.\"</li><li>More analyst comments: Guggenheim's Ken Wong says that Adobe's \"overall Marketo dilution likely came in higher than investors anticipated.\"</li><li>Marketo contributed $21M in revenue but would've taken $0.07 off of the non-GAAP EPS if included.</li><li>Adobe shares are <font color=\"red\">down 6%</font> to $233.13.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3416945-adobe-reports-mixed-q4-updates-fy-guidance\" target=\"_blank\">Adobe reports mixed Q4, updates FY guidance</a> (Dec. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417239\" data-linked=\"Analysts trim Adobe targets, express Marketo concerns\" data-tweet=\"$ADBE - Analysts trim Adobe targets, express Marketo concerns https://seekingalpha.com/news/3417239-analysts-trim-adobe-targets-express-marketo-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3417239-analysts-trim-adobe-targets-express-marketo-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417229\" data-ts=\"1544810499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHACU\" target=\"_blank\">CHACU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417229-chardan-healthcare-acquisition-debuts-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chardan Healthcare Acquisition debuts today</a></h4><ul><li>Blank Check company Chardan Capital Acquisition (<a href='https://seekingalpha.com/symbol/CHACU' title='Chardan Healthcare Acquisition'>CHACU</a>) should begin trading today. It is <a href=\"https://seekingalpha.com/pr/17358321-chardan-healthcare-acquisition-corp-announces-pricing-70-million-initial-public-offering\" target=\"_blank\">offering 7M Units at $10 per Unit</a>, each consisting of one ordinary share and one five-year warrant to purchase 1/2 of an ordinary share at $11.50.</li><li>Underwriter representative Chardan Capital Markets has an option to purchase up to an additional 1.05M Units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417229\" data-linked=\"Chardan Healthcare Acquisition debuts today\" data-tweet=\"$CHACU $PHGE - Chardan Healthcare Acquisition debuts today https://seekingalpha.com/news/3417229-chardan-healthcare-acquisition-debuts-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3417229-chardan-healthcare-acquisition-debuts-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417225\" data-ts=\"1544810143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIFS\" target=\"_blank\">CIFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417225-china-internet-nationwide-financial-services-only-financial-gainer-whereas-maiden-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Internet Nationwide Financial Services the only financial gainer whereas; Maiden Holdings leads losers</a></h4><ul><li><b>Gainers:</b> China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"green\">+14%</font>.</li><li><b>Losers:</b> Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"red\">-9%</font>. PPDAI Group (NYSE:<a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a>) <font color=\"red\">-9%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-8%</font>. Wheeler Real Estate Investment Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a>) <font color=\"red\">-6%</font>. American Finance Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/AFIN' title='American Finance Trust, Inc'>AFIN</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417225\" data-linked=\"China Internet Nationwide Financial Services the only financial gainer whereas; Maiden Holdings leads losers\" data-tweet=\"$CIFS $CIFS $MHLD - China Internet Nationwide Financial Services the only financial gainer whereas; Maiden Holdings leads losers https://seekingalpha.com/news/3417225-china-internet-nationwide-financial-services-only-financial-gainer-whereas-maiden-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3417225-china-internet-nationwide-financial-services-only-financial-gainer-whereas-maiden-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417222\" data-ts=\"1544809350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALQA\" target=\"_blank\">ALQA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417222-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) <font color=\"green\">+40%</font>. Belmond (NYSE:<a href='https://seekingalpha.com/symbol/BEL' title='Belmond Ltd.'>BEL</a>) <font color=\"green\">+40%</font>. Civitas Solutions (NYSE:<a href='https://seekingalpha.com/symbol/CIVI' title='Civitas Solutions'>CIVI</a>) <font color=\"green\">+20%</font>. XPO Logistics (NYSEMKT:<a href='https://seekingalpha.com/symbol/XPO' title='XPO Logistics, Inc'>XPO</a>) <font color=\"green\">+14%</font>. Wheaton Precious Metals (NYSE:<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a>) <font color=\"green\">+14%</font>. China Internet Nationwide Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"green\">+14%</font>. Fusion Connect (NASDAQ:<a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a>) <font color=\"green\">+13%</font>. iKang Healthcare Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KANG' title='iKang Healthcare Group, Inc.'>KANG</a>) <font color=\"green\">+11%</font>. Innovate Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a>) <font color=\"green\">+11%</font>. The Dixie Group (NASDAQ:<a href='https://seekingalpha.com/symbol/DXYN' title='The Dixie Group, Inc.'>DXYN</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>Draper Oakwood Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/DOTA' title='Draper Oakwood Technology Acquisition, Inc. Class A'>DOTA</a>) <font color=\"red\">-41%</font>. Good Times Restaurants (NASDAQ:<a href='https://seekingalpha.com/symbol/GTIM' title='Good Times Restaurants Inc.'>GTIM</a>) <font color=\"red\">-21%</font>. Aileron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a>) <font color=\"red\">-21%</font>. Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) <font color=\"red\">-19%</font>. DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a>) <font color=\"red\">-17%</font>. GEE Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/JOB' title='GEE Group, Inc.'>JOB</a>) <font color=\"red\">-16%</font>. Francesca's Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a>) <font color=\"red\">-13%</font>. Applied DNA Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a>) <font color=\"red\">-13%</font>. Cocrystal Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/COCP' title='Cocrystal Pharma, Inc.'>COCP</a>) <font color=\"red\">-13%</font>. YRC Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417222\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ALQA $ADYX $BEL - Midday Gainers / Losers https://seekingalpha.com/news/3417222-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3417222-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417220\" data-ts=\"1544808964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417220-healthcare-leads-markets-lower-j-and-j-plunges-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare leads markets lower as J&amp;J plunges 10%</a></h4><ul><li>Johnson &amp; Johnson is being stung <a href=\"https://seekingalpha.com/news/3417132-johnson-and-johnson-4-percent-reports-prior-knowledge-asbestos-baby-powder\" target=\"_blank\">by reports it knew</a> for years about contaminants in its baby powder. That's helping the Healthcare SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>) to a <font color=\"red\">3% decline</font> vs the S&amp;P 500's <font color=\"red\">1.2% fall</font>.</li><li>The Nasdaq is also <font color=\"red\">off 1.2%</font>, with Amazon, Apple, and Cisco all sporting <font color=\"red\">2%+ drops</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>, <a href='https://seekingalpha.com/symbol/VHT' title='Vanguard Health Care ETF'>VHT</a>, <a href='https://seekingalpha.com/symbol/IYH' title='iShares U.S. Healthcare ETF'>IYH</a>, <a href='https://seekingalpha.com/symbol/HQH' title='Tekla Healthcare Investors'>HQH</a>, <a href='https://seekingalpha.com/symbol/CURE' title='Direxion Daily Healthcare Bull 3x Shares ETF'>CURE</a>, <a href='https://seekingalpha.com/symbol/THQ' title='Tekla Healthcare Opportunities Fund'>THQ</a>, <a href='https://seekingalpha.com/symbol/FHLC' title='Fidelity MSCI Health Care Index ETF'>FHLC</a>, <a href='https://seekingalpha.com/symbol/FXH' title='First Trust Health Care AlphaDEX ETF'>FXH</a>, <a href='https://seekingalpha.com/symbol/RXL' title='ProShares Ultra Health Care ETF'>RXL</a>, <a href='https://seekingalpha.com/symbol/RYH' title='Invesco S&P Equal Weight Health Care ETF'>RYH</a>, <a href='https://seekingalpha.com/symbol/SICK' title='Daily Healthcare Bear 3x Shares ETF'>SICK</a>, <a href='https://seekingalpha.com/symbol/LNGR' title='Global X Longevity Thematic ETF'>LNGR</a>, <a href='https://seekingalpha.com/symbol/RXD' title='ProShares UltraShort Health Care ETF'>RXD</a>, <a href='https://seekingalpha.com/symbol/BTEC' title='Principal Healthcare Innovators Index ETF'>BTEC</a>, <a href='https://seekingalpha.com/symbol/JHMH' title='John Hancock Multifactor Healthcare ETF'>JHMH</a>, <a href='https://seekingalpha.com/symbol/HCRF' title='iShares Edge MSCI Multifactor Healthcare ETF'>HCRF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3417220\" data-linked=\"Healthcare leads markets lower as J&amp;J plunges 10%\" data-tweet=\"$XLV $VHT $IYH - Healthcare leads markets lower as J&amp;J plunges 10% https://seekingalpha.com/news/3417220-healthcare-leads-markets-lower-j-and-j-plunges-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3417220-healthcare-leads-markets-lower-j-and-j-plunges-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417217\" data-ts=\"1544808608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417217-sell-siders-defend-johnson-johnson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-siders defend Johnson &amp; Johnson</a></h4><ul><li>On cue, sell-side analysts are quickly discounting the revelations in the <a href=\"https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/\" target=\"_blank\">Reuters article </a>that Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-9.8%</font>) knew about the potential presence of asbestos in its baby powder for many years.</li><li>Wells Fargo: \"Stock oversold on the story.\"</li><li>Susquehanna: \"Reuters article not news.\"</li><li>JPMorgan: \"Selloff an over-reaction.\"</li><li>Citigroup: \"Company completely refutes Reuters article.\"</li><li>Jefferies: \"10% decline overdone.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3417217\" data-linked=\"Sell-siders defend Johnson &amp; Johnson\" data-tweet=\"$JNJ - Sell-siders defend Johnson &amp; Johnson https://seekingalpha.com/news/3417217-sell-siders-defend-johnson-johnson?source=tweet\" data-url=\"https://seekingalpha.com/news/3417217-sell-siders-defend-johnson-johnson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417216\" data-ts=\"1544808562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEE\" target=\"_blank\">SEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417216-sealed-airplus-4-after-unveiling-restructuring-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sealed Air +4% after unveiling restructuring plan</a></h4><ul><li>Sealed Air (<a href='https://seekingalpha.com/symbol/SEE' title='Sealed Air Corporation'>SEE</a> <font color='green'>+4.4%</font>) surges after announcing its Reinvent SEE strategy, including a <a href=\"https://seekingalpha.com/pr/17358242-sealed-air-announces-reinvent-see-strategy\" target=\"_blank\">new restructuring program</a> aimed at achieving $215M-$235M in annualized savings by year-end 2021.</li><li>The company says Reinvest SEE aims to drive growth with leading brands and packaging innovations for Fresh Food and e-Commerce and increase operating leverage target above 40%/year beginning in         2019.</li><li>SEE estimates total annualized savings from restructuring during the three year period of $240M-$260M, including $60M-$80M in savings during 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417216\" data-linked=\"Sealed Air +4% after unveiling restructuring plan\" data-tweet=\"$SEE - Sealed Air +4% after unveiling restructuring plan https://seekingalpha.com/news/3417216-sealed-airplus-4-after-unveiling-restructuring-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3417216-sealed-airplus-4-after-unveiling-restructuring-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417215\" data-ts=\"1544808024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417215-j-and-j-weighing-on-big-biopharma-players\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J weighing on big biopharma players</a></h4><ul><li>The broad market's bearish notwithstanding, members of Big Biopharma are under water pressured by the <a href=\"https://seekingalpha.com/news/3417132-johnson-and-johnson-4-percent-reports-prior-knowledge-asbestos-baby-powder\" target=\"_blank\">news </a>that Johnson &amp; Johnson may have known about contaminants in its baby powder for decades. The company is mired in thousands of product liability lawsuits that will take years to adjudicate.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"green\">+0.4%</font>)(<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color=\"red\">-2%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"red\">-1.9%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"red\">-1.1%</font>)(<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color=\"red\">-0.6%</font>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-2%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color=\"red\">-1.1%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-9.9%</font>)(<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"red\">-2.4%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color=\"red\">-1.9%</font>)(<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color=\"red\">-0.5%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"red\">-1.1%</font>)(<a href='https://seekingalpha.com/symbol/PKE' title='Park Electrochemical Corporation'>PKE</a> <font color=\"red\">-0.1%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color=\"red\">-0.5%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-1.3%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-2.5%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"red\">-1%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-1.8%</font>)(<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"red\">-1.7%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417215\" data-linked=\"J&amp;J weighing on big biopharma players\" data-tweet=\"$BHC $BHC $RHHBY - J&amp;J weighing on big biopharma players https://seekingalpha.com/news/3417215-j-and-j-weighing-on-big-biopharma-players?source=tweet\" data-url=\"https://seekingalpha.com/news/3417215-j-and-j-weighing-on-big-biopharma-players\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417209\" data-ts=\"1544807160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YETI\" target=\"_blank\">YETI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417209-yeti-holdings-leads-consumer-gainers-davidstea-and-libbey-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YETI Holdings leads consumer gainers;DAVIDsTEA and Libbey among losers</a></h4><ul><li><b>Gainers: </b>YETI Holdings (NYSE:<a href='https://seekingalpha.com/symbol/YETI' title='Yeti Holdings'>YETI</a>) <font color=\"green\">+6%</font>. Ardagh Group (NYSE:<a href='https://seekingalpha.com/symbol/ARD' title='Ardagh Group'>ARD</a>) <font color=\"green\">+5%</font>. Dogness (International) (NASDAQ:<a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation Class A'>DOGZ</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a>) <font color=\"red\">-17%</font>. Arcimoto (NASDAQ:<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a>) <font color=\"red\">-13%</font>. Libbey (NYSEMKT:<a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a>) <font color=\"red\">-6%</font>. Electrameccanica Vehicles (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLO' title='Electrameccanica Vehicles Corp. Ltd.'>SOLO</a>) <font color=\"red\">-6%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417209\" data-linked=\"YETI Holdings leads consumer gainers;DAVIDsTEA and Libbey among losers\" data-tweet=\"$YETI $YETI $ARD - YETI Holdings leads consumer gainers;DAVIDsTEA and Libbey among losers https://seekingalpha.com/news/3417209-yeti-holdings-leads-consumer-gainers-davidstea-and-libbey-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3417209-yeti-holdings-leads-consumer-gainers-davidstea-and-libbey-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417207\" data-ts=\"1544806632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSTM\" target=\"_blank\">CSTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417207-copper-drops-amid-weak-china-economic-data-freeport-mcmoranminus-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copper drops amid weak China economic data; Freeport McMoran -4%</a></h4><ul><li><a href=\"https://www.marketwatch.com/story/copper-slumps-on-weak-data-from-china-europe-2018-12-14\" target=\"_blank\">Copper prices tumble</a> alongside stocks and other risk assets, as disappointing economic data from China and Europe add to <a href=\"https://www.wsj.com/articles/new-data-from-china-and-europe-fan-economic-fears-11544803738\" target=\"_blank\">mounting concerns</a> that weakening growth at the end of this year will carry over into a sharper slowdown next year.</li><li>Comex copper for March delivery <font color=\"red\">-1.2%</font> to $2.733/lb. and are now down ~17% from their June four-year highs on fears that slower global economic growth will slow demand for materials used heavily in construction and manufacturing.</li><li>Elsewhere in base metals: aluminum <font color=\"red\">-0.6%</font> to $1,920/metric ton, zinc <font color=\"red\">-1.4%</font> to $2,529.50, tin <font color=\"red\">-0.2%</font> to $19,365, nickel <font color=\"red\">-0.3%</font> to $10,815, lead <font color=\"red\">-0.7%</font> at $1,935.50.</li><li>Among major industrial metals stocks: <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a> <font color=\"red\">-6.6%</font>, <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color=\"red\">-4.4%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color=\"red\">-2.7%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color=\"red\">-2.4%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color=\"red\">-2.1%</font>, <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color=\"red\">-0.7%</font>, <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color=\"red\">-0.3%</font>, <a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color=\"red\">-0.2%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLB' title='Materials Select Sector SPDR ETF'>XLB</a>, <a href='https://seekingalpha.com/symbol/JJCTF' title='iPath DJ-UBS Copper Total Return Sub-Index ETN'>OTCPK:JJCTF</a>, <a href='https://seekingalpha.com/symbol/BCX' title='BlackRock Resources&Commodities Strategy Trust'>BCX</a>, <a href='https://seekingalpha.com/symbol/PEO' title='Adams Natural Resources Fund, Inc.'>PEO</a>, <a href='https://seekingalpha.com/symbol/VAW' title='Vanguard Materials ETF'>VAW</a>, <a href='https://seekingalpha.com/symbol/COPX' title='Global X Copper Miners ETF'>COPX</a>, <a href='https://seekingalpha.com/symbol/DBB' title='Invesco DB Base Metals ETF'>DBB</a>, <a href='https://seekingalpha.com/symbol/UYM' title='ProShares Ultra Basic Materials ETF'>UYM</a>, <a href='https://seekingalpha.com/symbol/IYM' title='iShares U.S. Basic Materials ETF'>IYM</a>, <a href='https://seekingalpha.com/symbol/JJN' title='iPath DJ-UBS Nickel Total Return Sub-Index ETN'>JJN</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/GNR' title='SPDR S&P Global Natural Resources ETF'>GNR</a>, <a href='https://seekingalpha.com/symbol/HAP' title='VanEck Vectors Natural Resources ETF'>HAP</a>, <a href='https://seekingalpha.com/symbol/FMAT' title='Fidelity MSCI Materials Index ETF'>FMAT</a>, <a href='https://seekingalpha.com/symbol/MXI' title='iShares Global Materials ETF'>MXI</a>, SMN-OLD, <a href='https://seekingalpha.com/symbol/GUNR' title='FlexShares Morningstar Global Upstream Natural Resources Index ETF'>GUNR</a>, <a href='https://seekingalpha.com/symbol/BOM' title='DB Base Metals Double Short ETN'>BOM</a>, <a href='https://seekingalpha.com/symbol/FXZ' title='First Trust Materials AlphaDEX ETF'>FXZ</a>, <a href='https://seekingalpha.com/symbol/BDD' title='DB Base Metals Double Long ETN'>BDD</a>, <a href='https://seekingalpha.com/symbol/RTM' title='Invesco S&P Equal Weight Materials ETF'>RTM</a>, <a href='https://seekingalpha.com/symbol/BOS' title='DB Base Metals Short ETN'>BOS</a>, <a href='https://seekingalpha.com/symbol/RJZ' title='ELEMENTS Rogers International Commodity Metal ETN'>RJZ</a>, <a href='https://seekingalpha.com/symbol/GRES' title='IQ ARB Global Resources ETF'>GRES</a>, <a href='https://seekingalpha.com/symbol/SBM' title='ProShares Short Basic Materials ETF'>SBM</a>, <a href='https://seekingalpha.com/symbol/BDG-OLD' title='DB Base Metals Long ETN'>BDG-OLD</a>, <a href='https://seekingalpha.com/symbol/UBM' title='UBS ETRACS CMCI Industrial Metals Total Return ETN'>UBM</a>, <a href='https://seekingalpha.com/symbol/JHMA' title='John Hancock Multifactor Materials ETF'>JHMA</a>, <a href='https://seekingalpha.com/symbol/JJUB' title='iPath Series B Bloomberg Aluminum Subindex Total Return ETN'>JJUB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3417207\" data-linked=\"Copper drops amid weak China economic data; Freeport McMoran -4%\" data-tweet=\"$CSTM $CSTM $FCX - Copper drops amid weak China economic data; Freeport McMoran -4% https://seekingalpha.com/news/3417207-copper-drops-amid-weak-china-economic-data-freeport-mcmoranminus-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3417207-copper-drops-amid-weak-china-economic-data-freeport-mcmoranminus-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417206\" data-ts=\"1544806594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417206-european-advisory-group-backs-expanded-use-for-clovis-rubraca\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs expanded use for Clovis&#39; Rubraca</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a positive opinion <a href=\"https://www.ema.europa.eu/documents/smop/chmp-post-authorisation-summary-positive-opinion-rubraca-ii-01_en.pdf\" target=\"_blank\">recommending approva</a>l to use Clovis Oncology's (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color=\"red\">-7.5%</font>) Rubraca (rucaparib) as monotherapy for  the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy.</li><li>Rubraca is currently approved in the EU for adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy.</li><li>A final decision from the European Commission usually takes ~60 days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417206\" data-linked=\"European advisory group backs expanded use for Clovis&#39; Rubraca\" data-tweet=\"$CLVS - European advisory group backs expanded use for Clovis&#39; Rubraca https://seekingalpha.com/news/3417206-european-advisory-group-backs-expanded-use-for-clovis-rubraca?source=tweet\" data-url=\"https://seekingalpha.com/news/3417206-european-advisory-group-backs-expanded-use-for-clovis-rubraca\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417198\" data-ts=\"1544805992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITB\" target=\"_blank\">LITB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417198-lightintheboxplus-7-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LightInTheBox +7% post Q3 results</a></h4><ul><li>LightInTheBox (<a href='https://seekingalpha.com/symbol/LITB' title='LightInTheBox Holding Co., Ltd.'>LITB</a> <font color=\"green\">+7.7%</font>) reported Q3 revenue decrease of 42.3% Y/Y to $44.5M. Revenue by Product sales $42.91M (-40.7% Y/Y) and Services &amp; others $1.59M (-66% Y/Y).</li><li>Total orders of product sales were 0.8M, compared 1.7M a year ago.</li><li>Product sales: Europe was $21.2M (-44.8% Y/Y), North America was $10.9M (-38.2% Y/Y), Gulf Cooperation Council countries was $2.6M, and other countries were $8.2M.</li><li>Q3 Gross profit <font color=\"red\">declined by 2,110 bps</font> to 15.1%.</li><li>Q3 Loss from operations was $18.1M, compared to $2M a year ago.</li><li>Company has cash and cash equivalents and restricted cash of $38.3M, as of September 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3417083-lightinthebox-reports-q3-results\" target=\"_blank\">LightInTheBox reports Q3 results</a> (Dec. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417198\" data-linked=\"LightInTheBox +7% post Q3 results\" data-tweet=\"$LITB - LightInTheBox +7% post Q3 results https://seekingalpha.com/news/3417198-lightintheboxplus-7-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3417198-lightintheboxplus-7-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417162\" data-ts=\"1544805748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417162-financials-lose-least-in-market-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials lose the least in market decline</a></h4><ul><li>The financial sector loses the least (<font color=\"red\">-0.4%</font>) on Friday heading into midday, with some financial names actually making gains.</li><li>Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color=\"green\">+1.3%</font>) gains after Morgan Stanley analyst Betsy Graseck defends the stock.</li><li>U.S-based megabanks waver between rising and falling for much of the morning. Now, they're down: Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color=\"red\">-0.2%</font>), Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color=\"red\">-0.3%</font>), JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color=\"red\">-0.2%</font>).</li><li>U.S. regional banks, though, are mixed: Comerica (<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Inc.'>CMA</a> <font color=\"green\">+0.3%</font>), PNC Financial (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color=\"green\">+0.1%</font>), and Axos Financial (<a href='https://seekingalpha.com/symbol/AX' title='Axos Financial, Inc.'>AX</a> <font color=\"green\">+0.1%</font>) lead, with  CIT Group (<a href='https://seekingalpha.com/symbol/CIT' title='CIT Group Inc.'>CIT</a> <font color=\"red\">-1%</font>), U.S. Bancorp (<a href='https://seekingalpha.com/symbol/USB' title='U.S. Bancorp'>USB</a> <font color=\"red\">-1.1%</font>) and Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color=\"red\">-0.8%</font>) lagging.</li><li>Auto lenders -- Ally Financial (<a href='https://seekingalpha.com/symbol/ALLY' title='Ally Financial Inc.'>ALLY</a> <font color=\"green\">+0.8%</font>), Santander Consumer USA (<a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc'>SC</a> <font color=\"green\">+1.7%</font>), and Credit Acceptance (<a href='https://seekingalpha.com/symbol/CACC' title='Credit Acceptance Corporation'>CACC</a> <font color=\"green\">+1.6%</font>) -- move up strongly.</li><li>Online brokers Charles Schwab (<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a> <font color=\"green\">+0.4%</font>), E*Trade (<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a> <font color=\"green\">+0.9%</font>),  and TD Ameritrade (<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>) also gain.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417162\" data-linked=\"Financials lose the least in market decline\" data-tweet=\"$BAC $BAC $C - Financials lose the least in market decline https://seekingalpha.com/news/3417162-financials-lose-least-in-market-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3417162-financials-lose-least-in-market-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417195\" data-ts=\"1544805312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417195-amcu-union-says-remains-on-strike-sibanye-stillwater\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMCU union says it remains on strike at Sibanye-Stillwater</a></h4><ul><li>Sibanye-Stillwater (<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-2.6%</font>) is lower after the president of South Africa\u2019s AMCU union said its members <a href=\"https://af.reuters.com/article/investingNews/idAFKBN1OD12Q-OZABS\" target=\"_blank\">remain on strike</a>, disputing the miner\u2019s position that the <a href=\"https://seekingalpha.com/news/3416728-sibanye-extends-union-wage-deals-employees-likely-ending-amcu-strike\" target=\"_blank\">action is now illegal</a>.</li><li>The union says its members should not to report to work, \"as they are still in a protected strike until their demands have been met\"; the company says the strike is now unprotected according to South African labor laws, and employees who fail to return to work would be subject to disciplinary measures.</li><li>AMCU, which represents ~43% of SBGL\u2019s gold workforce in South Africa, called the strike in mid-November after discussions over wages broke down.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417195\" data-linked=\"AMCU union says it remains on strike at Sibanye-Stillwater\" data-tweet=\"$SBGL - AMCU union says it remains on strike at Sibanye-Stillwater https://seekingalpha.com/news/3417195-amcu-union-says-remains-on-strike-sibanye-stillwater?source=tweet\" data-url=\"https://seekingalpha.com/news/3417195-amcu-union-says-remains-on-strike-sibanye-stillwater\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417192\" data-ts=\"1544805015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDB\" target=\"_blank\">MDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417192-needham-raises-mongodb-target-on-roadmap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham raises MongoDB target on roadmap</a></h4><ul><li>Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/MongoDB+%28MDB%29+PT+Raised+to+%2497+at+Needham+%26+Company/14923835.html\" target=\"_blank\">maintains</a> a Buy rating on MongoDB (NASDAQ:<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a>) and raises the price target by $6 to $97.</li><li>Analyst Jack Andrews cites a meeting and call with management that left the firm believing that \"MDB's product roadmap has a multi-year feature advantage in meeting the requirements of modern applications over most competitors.\"</li><li>MDB is <font color=\"green\">up 1%</font> to $90.48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417192\" data-linked=\"Needham raises MongoDB target on roadmap\" data-tweet=\"$MDB - Needham raises MongoDB target on roadmap https://seekingalpha.com/news/3417192-needham-raises-mongodb-target-on-roadmap?source=tweet\" data-url=\"https://seekingalpha.com/news/3417192-needham-raises-mongodb-target-on-roadmap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417189\" data-ts=\"1544804848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417189-new-residential-bounces-kbw-advises-buying-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Residential bounces as KBW advises buying the dip</a></h4><ul><li>It's been a rough fall for New Residential (NYSE:<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a>), with shares <font color=\"red\">down about 20% </font>since Labor Day. This makes for an attractive entry point, says KBW bull Bose George, noting the stock now changes hands at just 92% of trailing book value.</li><li>George says the particularly sharp drop of the past two weeks is mostly thanks to reset expectations on interest rates - lower rates negatively impact the value of NRZ's portfolio of mortgage servicing rights. George, however, figures the MSR mark will be rather modest, perhaps 1-2%.</li><li>There's also NRZ's clean-up call rights - they're not represented in book value, but will flow through to earnings. George figures these rights alone are worth $1.75 per share.</li><li>George reiterates his Outperform rating and $19 price target.</li><li>Shares <font color=\"green\">+1.8%</font> today to $15.85.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417189\" data-linked=\"New Residential bounces as KBW advises buying the dip\" data-tweet=\"$NRZ - New Residential bounces as KBW advises buying the dip https://seekingalpha.com/news/3417189-new-residential-bounces-kbw-advises-buying-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3417189-new-residential-bounces-kbw-advises-buying-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417186\" data-ts=\"1544804753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417186-credit-suisse-defends-j-b-hunt-transport-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse defends J.B. Hunt Transport Services</a></h4><ul> <li>Credit Suisse thinks the announcement by J.B. Hunt Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color='red'>-2.8%</font>) of a charge related to BNSF arbitration (<a href=\"https://seekingalpha.com/filing/4269748\" target=\"_blank\">SEC Form 8-K</a>) could be a negative signal for margins in 2019, although the firm remain positive on the set-up for the upcoming year.</li> <li>\"Despite a ~20% pullback in the stock since the beginning of Q4, we continue to be bullish on JBHT given the \u201919 EPS power and the improving return profile,\" writes analyst Allison Landry.</li> <li>\"Specifically, we recognize 1) the pipeline for DCS growth with 30+ new customers, 2) potential pricing power in \u201919 as JBHT pulls the lever on price rather than volumes, and 3) Marketplace 360, which supports efficiency and asset utilization,\" she adds.</li> <li>Credit Suisse keeps an Outperform rating on JBHT and price target of $148 (+50% upside potential).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417186\" data-linked=\"Credit Suisse defends J.B. Hunt Transport Services\" data-tweet=\"$JBHT - Credit Suisse defends J.B. Hunt Transport Services https://seekingalpha.com/news/3417186-credit-suisse-defends-j-b-hunt-transport-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3417186-credit-suisse-defends-j-b-hunt-transport-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417185\" data-ts=\"1544804647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBL\" target=\"_blank\">JBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417185-rbc-lowers-jabil-target-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC lowers Jabil target ahead of earnings</a></h4><ul><li>RBC Capital <a href=\"https://www.streetinsider.com/Analyst+Comments/Jabil+Circuit+%28JBL%29+PT+Lowered+to+%2429+at+RBC+Capital/14923845.html\" target=\"_blank\">maintains</a> a Sector Perform rating on Jabil (NYSE:<a href='https://seekingalpha.com/symbol/JBL' title='Jabil Inc.'>JBL</a>) and lowers the target from $33 to $29.</li><li>Jabil will report earnings on December 18. Analysts <a href=\"https://seekingalpha.com/symbol/JBL/earnings/estimates\" target=\"_blank\">expect</a> $0.88 EPS and $6.1B in revenue.</li><li>Jabil shares are <font color=\"red\">down 0.5%</font> to $22.14.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417185\" data-linked=\"RBC lowers Jabil target ahead of earnings\" data-tweet=\"$JBL - RBC lowers Jabil target ahead of earnings https://seekingalpha.com/news/3417185-rbc-lowers-jabil-target-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3417185-rbc-lowers-jabil-target-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417182\" data-ts=\"1544804357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417182-splunk-anaplan-move-on-hedgeye-mentions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk, Anaplan move on Hedgeye mentions</a></h4><ul><li>Splunk (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>) shares are <font color=\"red\">down 1%</font> after <a href=\"https://www.streetinsider.com/Analyst+Comments/Splunk+%28SPLK%29+Short%2C+Anaplan+%28PLAN%29+Long+Recommended+by+Hedgeye+Tech+Analyst+-+Bloomberg/14924713.html\" target=\"_blank\">headlines</a> that Hedgeye recommends short Splunk, long Anaplan (NYSE:<a href='https://seekingalpha.com/symbol/PLAN' title='Anaplan, Inc.'>PLAN</a>), which is <font color=\"green\">up 1.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417182\" data-linked=\"Splunk, Anaplan move on Hedgeye mentions\" data-tweet=\"$SPLK $SPLK $PLAN - Splunk, Anaplan move on Hedgeye mentions https://seekingalpha.com/news/3417182-splunk-anaplan-move-on-hedgeye-mentions?source=tweet\" data-url=\"https://seekingalpha.com/news/3417182-splunk-anaplan-move-on-hedgeye-mentions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417181\" data-ts=\"1544804265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNI\" target=\"_blank\">MNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417181-mcclatchyplus-6_5-after-report-tribune-publishing-bid-is-rejected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McClatchy +6.5% after report its Tribune Publishing bid is rejected</a></h4><ul>   <li>Tribune Publishing (<a href=\"http://seekingalpha.com/symbol/TPCO\" target=\"_blank\">TPCO</a> <font color=\"green\">+0.5%</font>) shares are sanguine, but McClatchy (NYSEMKT:<a href='https://seekingalpha.com/symbol/MNI' title='The McClatchy Company'>MNI</a>) is <font color=\"green\">up 6.5%</font>, after a Bloomberg report that Tribune Publishing rejected McClatchy's $16.50/share buyout offer.</li>    <li>Tribune is talking to other buyers rather than going for the fully financed cash-and-stock offer, according to the report ($15/share in cash).</li>    <li>Tribune Publishing is settling at $13.65 today, suggesting some skepticism that a higher offer might come in. Tribune's top shareholder, former Chairman Michael Ferro, had suggested he wanted to see $19-$20/share.</li>    <li>Focus now turns to a joint Donerail/AIM Media bid; the two <a href=\"https://seekingalpha.com/news/3404922-tribune-publishing-gets-bids-donerail-aim-mcclatchy\" target=\"_blank\">put in an offer</a> last month alongside McClatchy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417181\" data-linked=\"McClatchy +6.5% after report its Tribune Publishing bid is rejected\" data-tweet=\"$MNI $MNI $TPCO - McClatchy +6.5% after report its Tribune Publishing bid is rejected https://seekingalpha.com/news/3417181-mcclatchyplus-6_5-after-report-tribune-publishing-bid-is-rejected?source=tweet\" data-url=\"https://seekingalpha.com/news/3417181-mcclatchyplus-6_5-after-report-tribune-publishing-bid-is-rejected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417176\" data-ts=\"1544803575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALQA\" target=\"_blank\">ALQA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417176-alliqua-biomedical-and-tenax-therapeutics-among-healthcare-gainer-idera-pharmaceuticals-leads\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliqua BioMedical and Tenax Therapeutics among healthcare gainer; Idera Pharmaceuticals leads the losers</a></h4><ul><li><b>Gainers: </b>Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) <font color=\"green\">+48%</font>. Civitas Solutions (NYSE:<a href='https://seekingalpha.com/symbol/CIVI' title='Civitas Solutions'>CIVI</a>) <font color=\"green\">+15%</font>. iKang Healthcare Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KANG' title='iKang Healthcare Group, Inc.'>KANG</a>) <font color=\"green\">+10%</font>. Teligent (NASDAQ:<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a>) <font color=\"green\">+7%</font>. Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) <font color=\"red\">-20%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-16%</font>. Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) <font color=\"red\">-13%</font>. Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a>) <font color=\"red\">-11%</font>. Sienna Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNNA' title='Sienna Biopharmaceuticals'>SNNA</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417176\" data-linked=\"Alliqua BioMedical and Tenax Therapeutics among healthcare gainer; Idera Pharmaceuticals leads the losers\" data-tweet=\"$ALQA $ADYX $CIVI - Alliqua BioMedical and Tenax Therapeutics among healthcare gainer; Idera Pharmaceuticals leads the losers https://seekingalpha.com/news/3417176-alliqua-biomedical-and-tenax-therapeutics-among-healthcare-gainer-idera-pharmaceuticals-leads?source=tweet\" data-url=\"https://seekingalpha.com/news/3417176-alliqua-biomedical-and-tenax-therapeutics-among-healthcare-gainer-idera-pharmaceuticals-leads\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417175\" data-ts=\"1544803469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417175-walgreensminus-4-after-goldman-gloom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens -4% after Goldman gloom</a></h4><ul> <li>Walgreen Boots Alliance (<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color=\"red\">-3.7%</font>) slumps after taking on a biting <a href=\"https://www.marketwatch.com/story/walgreens-stock-falls-after-goldman-cuts-to-sell-on-intensified-retail-pharmacy-challenges-2018-12-14\" target=\"_blank\">downgrade</a> from Goldman Sachs.</li> <li>\"We downgrade WBA to Sell as challenges in its retail pharmacy business have intensified, forcing the company to search for other avenues of growth,\" writes the Goldman analyst team.</li> <li>The firm also warns on \"peak\" retail pharmacy pricing and doesn't see a path for EBIT to improve.</li> <li>Walgreens is also seen as limited in shifting its focus. \"We think WBA's balance sheet could be a limiting factor in making a more meaningful strategic pivot,\" warns GS.</li><li>Walgreens was rated by GS at Neutral before today's cut.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417175\" data-linked=\"Walgreens -4% after Goldman gloom\" data-tweet=\"$WBA - Walgreens -4% after Goldman gloom https://seekingalpha.com/news/3417175-walgreensminus-4-after-goldman-gloom?source=tweet\" data-url=\"https://seekingalpha.com/news/3417175-walgreensminus-4-after-goldman-gloom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417173\" data-ts=\"1544803206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADXS\" target=\"_blank\">ADXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417173-advaxis-down-36-on-amgen-exit-from-adxs-neo-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advaxis down 36% on Amgen exit from ADXS-NEO program</a></h4><ul><li>Nano cap Advaxis (<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color=\"red\">-36.4%</font>) is down on triple normal volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1100397/000149315218017447/form8-k.htm\" target=\"_blank\">disclosure </a>that exclusive licensee Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-1.6%</font>) will exit the ADXS-NEO program effective February 8, 2019.</li><li>The company says the Phase 1 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03265080?lead=advaxis&amp;rank=1\" target=\"_blank\">NEO study</a> will continue enrolling patients while it assesses whether to seek another development partner.</li><li><a href=\"https://www.advaxis.com/clinical-trials-3/mine/\" target=\"_blank\">ADXS-NEO</a> is a personalized immunotherapy that stimulates an anti-cancer immune response based on a patient's unique tumor mutations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417173\" data-linked=\"Advaxis down 36% on Amgen exit from ADXS-NEO program\" data-tweet=\"$ADXS $ADXS $AMGN - Advaxis down 36% on Amgen exit from ADXS-NEO program https://seekingalpha.com/news/3417173-advaxis-down-36-on-amgen-exit-from-adxs-neo-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3417173-advaxis-down-36-on-amgen-exit-from-adxs-neo-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417169\" data-ts=\"1544802485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLNW\" target=\"_blank\">LLNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417169-limelight-networksminus-6_4-in-second-decline-after-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limelight Networks -6.4% in second decline after guidance cut</a></h4><ul>   <li>Limelight Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a>) is falling for a second day, <font color=\"red\">down 6.4%</font>, after a <a href=\"https://seekingalpha.com/news/3416601-limelight-networks-slips-13-percent-trimmed-2018-guidance\" target=\"_blank\">late Wednesday guidance cut</a> sent shares falling in the postmarket.</li>    <li>Shares <font color=\"red\">tumbled 19.3%</font> yesterday during market hours after the cutback.</li>    <li>B. Riley says the stock's \"in the penalty box\" after what it termed a major disappointment in the guidance. The firm cut its price target to $5 from $6 -- though after the declines, that leaves implied upside at 107%.</li>    <li>Valuation's still \"very reasonable\" and the company has the chance to add multiple U.S. broadcasting customers for the first time in 10 years, a \"significant\" positive, the firm says.</li>    <li>Limelight's new 2018 guidance for revenue of $195M-$196M and EPS of $0.10-$0.11 both trailed Street expectations.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417169\" data-linked=\"Limelight Networks -6.4% in second decline after guidance cut\" data-tweet=\"$LLNW - Limelight Networks -6.4% in second decline after guidance cut https://seekingalpha.com/news/3417169-limelight-networksminus-6_4-in-second-decline-after-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3417169-limelight-networksminus-6_4-in-second-decline-after-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417168\" data-ts=\"1544802406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417168-clovis-down-7-on-diminished-prospects-for-takeover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clovis down 7% on diminished prospects for takeover</a></h4><ul><li>Clovis Oncology (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color=\"red\">-7.1%</font>) is down on modestly higher volume in apparent response to a <a href=\"https://www.sec.gov/Archives/edgar/data/1491576/000104746918007661/a2237269zsc14d9.htm\" target=\"_blank\">regulatory filing</a> by competitor TESARO (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color=\"red\">-0.7%</font>) detailing its $75/share takeover bid from GlaxoSmithKline (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color=\"red\">-1%</font>).</li><li>TESARO's review of strategic alternatives revealed that the majority of companies were more interested in royalty, licensing or co-development deals rather than an outright acquisition, dampening the prospects for a suitor for Clovis.</li><li>The background on GSK's offer begin on page 14 in the <a href=\"https://www.sec.gov/Archives/edgar/data/1491576/000104746918007661/a2237269zsc14d9.htm\" target=\"_blank\">document</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417168\" data-linked=\"Clovis down 7% on diminished prospects for takeover\" data-tweet=\"$CLVS $CLVS $TSRO - Clovis down 7% on diminished prospects for takeover https://seekingalpha.com/news/3417168-clovis-down-7-on-diminished-prospects-for-takeover?source=tweet\" data-url=\"https://seekingalpha.com/news/3417168-clovis-down-7-on-diminished-prospects-for-takeover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417156\" data-ts=\"1544801125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRAD\" target=\"_blank\">LRAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417156-lradplus-9-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LRAD +9% post Q4 results</a></h4><ul><li>LRAD (<a href='https://seekingalpha.com/symbol/LRAD' title='LRAD Corp'>LRAD</a> <font color=\"green\">+9.6%</font>) reported Q4 revenue decreased 56.1% Y/Y to $3.29M, due to September scheduled shipments totaling $4.7M that did not ship due to government funding issues.</li><li>Q4 Gross margin <font color=\"red\">declined by 2,701 bps</font> to 31.8% and operating margin <font color=\"red\">declined by 10,221 bps</font> to -87.5%.</li><li>Q4 Expenses increased 18% Y/Y to $3.94M, with SG&amp;A $3.08M (+14.7% Y/Y) and R&amp;D $859k (+34.01% Y/Y).</li><li>Bookings YTD were $36.5M, up 29% Y/Y, resulting in a record backlog of $23.6M.</li><li>During the quarter company repurchased 286,746 shares for $725,445, or $2.53 per share. $3.2 million remains on the buyback program as of September 30, 2018.</li><li>Company\u2019s Board authorized a new $5M repurchase program that is in place through December 31, 2020.</li><li>Company has Cash and cash equivalents of $11.1M as of September 30, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3416964-lrad-reports-q4-results\" target=\"_blank\">LRAD reports Q4 results</a> (Dec. 13)</li><li><a href=\"https://seekingalpha.com/article/4228256-lrad-corporation-lrad-ceo-richard-danforth-q4-2018-results-earnings-call-transcript?part=single\" target=\"_blank\">Transcript</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3417156\" data-linked=\"LRAD +9% post Q4 results\" data-tweet=\"$LRAD $GNSS - LRAD +9% post Q4 results https://seekingalpha.com/news/3417156-lradplus-9-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3417156-lradplus-9-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417158\" data-ts=\"1544801113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BID\" target=\"_blank\">BID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417158-accelerated-buybacks-sothebys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accelerated buybacks at Sotheby&#39;s</a></h4><ul> <li>Sotheby's (<a href='https://seekingalpha.com/symbol/BID' title='Sotheby&#39;s'>BID</a> <font color='green'>+3.9%</font>) announces that it will repurchase up to $70M worth of shares as part of an accelerated share repurchase program.</li><li>Under the ASR agreement, Sotheby's will receive an initial delivery of approximately 1,605,938 shares. The repurchase is part of the company's previously announced share repurchase authorization.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17358834-sothebys-announces-repurchases-accelerated-share-repurchase-program\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3417158\" data-linked=\"Accelerated buybacks at Sotheby&#39;s\" data-tweet=\"$BID - Accelerated buybacks at Sotheby&#39;s https://seekingalpha.com/news/3417158-accelerated-buybacks-sothebys?source=tweet\" data-url=\"https://seekingalpha.com/news/3417158-accelerated-buybacks-sothebys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417152\" data-ts=\"1544800124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MG\" target=\"_blank\">MG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417152-mistras-to-buy-pipeline-inspection-and-data-analytics-platform-for-143m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mistras to buy pipeline inspection and data analytics platform for $143M</a></h4><ul><li>Mistras Group (<a href='https://seekingalpha.com/symbol/MG' title='MISTRAS Group, Inc.'>MG</a> <font color='green'>+1.5%</font>) opens higher after <a href=\"https://seekingalpha.com/pr/17358124-mistras-group-announces-acquisition-onstream-pipeline-inspection-143-million-increases-fiscal\" target=\"_blank\">agreeing to acquire</a> Onstream Pipeline Inspection, a provider of pipeline inspection and data  analytics services primarily to the gathering and midstream market, for $143M.</li><li>The company also updates its FY 2018 revenue guidance to $740M, an increase of $10M over the high end  of its most recent outlook and excluding the impact from Onstream.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417152\" data-linked=\"Mistras to buy pipeline inspection and data analytics platform for $143M\" data-tweet=\"$MG - Mistras to buy pipeline inspection and data analytics platform for $143M https://seekingalpha.com/news/3417152-mistras-to-buy-pipeline-inspection-and-data-analytics-platform-for-143m?source=tweet\" data-url=\"https://seekingalpha.com/news/3417152-mistras-to-buy-pipeline-inspection-and-data-analytics-platform-for-143m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417144\" data-ts=\"1544799702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTIM\" target=\"_blank\">GTIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417144-good-times-restaurants-slides-21_1-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Good Times Restaurants slides 21.1% post Q4 results</a></h4><ul><li>Good Times Restaurants (<a href='https://seekingalpha.com/symbol/GTIM' title='Good Times Restaurants Inc.'>GTIM</a> <font color=\"red\">-21.1%</font>) reports <a href=\"https://seekingalpha.com/pr/17358146-good-times-restaurants-reports-q4-fiscal-year-end-results\" target=\"_blank\">Q4</a> revenue growth of 19.5% Y/Y to $26.79M.</li><li>Same store sales for company-owned Good Times restaurants increased 0.5%; YTD, same store sales increased 4.2%.</li><li>Sales for the Bad Daddy\u2019s restaurants increased <font color=\"green\">33.6%</font> Y/Y to $18.7M.</li><li>Bad Daddy\u2019s same store sales increased 0.7%; YTD, same store sales increased 0.8%.</li><li>Restaurant Level operating profit margin <font color=\"green\">increased 228 bps</font> to 11.57%.</li><li>Bad Daddy\u2019s Restaurant Level operating profit margin <font color=\"green\">improved 120 bps</font> to to 17%.</li><li>Adj. EBITDA margin <font color=\"green\">increased 53 bps</font> to 6.7%.</li><li>The Company ended the year with $3.5M in cash and $7.5M of long term debt.</li><li><b>2019 Outlook:</b> Revenues of ~$112-114M; Same store sales of ~-2% to -3% for Good Times and and assumes ~+1% to +2% for Bad Daddy\u2019s; G&amp;A of ~$8.4-8.6M; Adj. EBITDA ~$6-6.5M; Capex of ~$7-7.5M; Long term debt of ~$11-11.5M &amp; Opening of a total of 5-6 new company-owned Bad Daddy\u2019s restaurants.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3416924-good-times-restaurants-beats-0_01-beats-revenue\" target=\"_blank\">Good Times Restaurants beats by $0.01, beats on revenue</a> (Dec. 13 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417144\" data-linked=\"Good Times Restaurants slides 21.1% post Q4 results\" data-tweet=\"$GTIM - Good Times Restaurants slides 21.1% post Q4 results https://seekingalpha.com/news/3417144-good-times-restaurants-slides-21_1-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3417144-good-times-restaurants-slides-21_1-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417139\" data-ts=\"1544798818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEE\" target=\"_blank\">LEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417139-leeplus-8_2-profits-grow-amid-digital-transition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lee +8.2% as profits grow amid digital transition</a></h4><ul>   <li>Lee Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/LEE' title='Lee Enterprises, Incorporated'>LEE</a>) is <font color=\"green\">up 8.2%</font> following <a href=\"https://seekingalpha.com/news/3417035-lee-reports-q4-results\" target=\"_blank\">Q4 results</a> where it grew earnings in an environment where growing subscriptions are making up for ad declines.</li>    <li>Net gain was $4.4M, vs. a year-ago $3.5M, against revenue that was nearly flat.</li>    <li>Digital revenue (ads and services), though, rose 12.6%.</li>    <li>Monthly visits to Lee's mobile, tablet, desktop and app sites averaged 79.8M (up 12.4%).</li>    <li>Revenue breakout: Advertising and marketing services, $73.7M (down 7.4%); Subscription, $52.7M (up 4.1%); other, $13.35M (up 32.8%).</li>    <li>Liquidity was $39.6M, against $7M in debt principal payments required over the next 12 months. The company's revolving facility expires in two weeks.</li>    <li><a href=\"http://www.lee.net/\" target=\"_blank\">Conference call</a> to come at 10 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17358479-lee-enterprises-continues-strong-digital-transformation-reports-fiscal-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3417139\" data-linked=\"Lee +8.2% as profits grow amid digital transition\" data-tweet=\"$LEE - Lee +8.2% as profits grow amid digital transition https://seekingalpha.com/news/3417139-leeplus-8_2-profits-grow-amid-digital-transition?source=tweet\" data-url=\"https://seekingalpha.com/news/3417139-leeplus-8_2-profits-grow-amid-digital-transition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417137\" data-ts=\"1544798439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIMO\" target=\"_blank\">SIMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417137-morgan-stanley-steps-to-side-on-silicon-motion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley steps to side on Silicon Motion</a></h4><ul><li>Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Morgan+Stanley+Downgrades+Silicon+Motion+Technology+%28SIMO%29+to+Equalweight/14923346.html\" target=\"_blank\">downgrades</a> Silicon Motion (NASDAQ:<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a>) from Overweight to Equal-Weight.</li><li>SIMO was one of the chip stocks on a wild ride this quarter as Apple guided a soft holiday quarter and suppliers lined up to cut guidance. SIMO shares are <font color=\"red\">down 36.5%</font> in the quarter and <font color=\"red\">35%</font> YTD.</li><li>SIMO shares are <font color=\"red\">down 5.5%</font> to $32.55.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417137\" data-linked=\"Morgan Stanley steps to side on Silicon Motion\" data-tweet=\"$SIMO - Morgan Stanley steps to side on Silicon Motion https://seekingalpha.com/news/3417137-morgan-stanley-steps-to-side-on-silicon-motion?source=tweet\" data-url=\"https://seekingalpha.com/news/3417137-morgan-stanley-steps-to-side-on-silicon-motion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417132\" data-ts=\"1544798153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417132-johnson-johnson-down-4-on-reports-of-prior-knowledge-of-asbestos-in-baby-powder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Johnson &amp; Johnson down 4% on reports of prior knowledge of asbestos in baby powder</a></h4><ul><li>Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-3.7%</font>) is down out the gate this morning on <a href=\"https://www.streetinsider.com/Litigation/Special+Report%3A+J%26J+knew+for+decades+that+asbestos+lurked+in+its+Baby+Powder/14924366.html\" target=\"_blank\">reports </a>that it knew for decades that its baby powder could be contaminated with asbestos.</li><li>The earliest mention on possible contaminants was in the late 1950s from a consulting lab, according to <a href=\"https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/\" target=\"_blank\">Reuters</a> who has examined thousands of pages of company documents as well as deposition and trial testimony. It found that, from 1971 to the early 2000s, company executives and others (including doctors and lawyers) fretted over the problem and how to address it while avoiding disclosure.</li><li>The company is working through almost 12K product liability lawsuits related to alleged consumer harm from long-term use of its baby powder and continues to deny prior knowledge of any contamination. It declined to comment further on the Reuters piece.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417132\" data-linked=\"Johnson &amp; Johnson down 4% on reports of prior knowledge of asbestos in baby powder\" data-tweet=\"$JNJ - Johnson &amp; Johnson down 4% on reports of prior knowledge of asbestos in baby powder https://seekingalpha.com/news/3417132-johnson-johnson-down-4-on-reports-of-prior-knowledge-of-asbestos-in-baby-powder?source=tweet\" data-url=\"https://seekingalpha.com/news/3417132-johnson-johnson-down-4-on-reports-of-prior-knowledge-of-asbestos-in-baby-powder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>148&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417127\" data-ts=\"1544797700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417127-activisionminus-1_8-needham-cuts-estimates-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activision -1.8% as Needham cuts estimates, price target</a></h4><ul>   <li>Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>) is <font color=\"red\">down 1.8%</font> premarket after a price target cut at Needham.</li>    <li>The firm reduced its target to $60 from $90 (still implying 24% upside) and cut revenue and EPS estimates for the coming year, pointing to downward revisions from the Blizzard side of the business.</li>    <li>It still rates the stock Buy.</li>    <li>Shares have <font color=\"red\">fallen 37.6%</font> over the past six months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417127\" data-linked=\"Activision -1.8% as Needham cuts estimates, price target\" data-tweet=\"$ATVI - Activision -1.8% as Needham cuts estimates, price target https://seekingalpha.com/news/3417127-activisionminus-1_8-needham-cuts-estimates-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3417127-activisionminus-1_8-needham-cuts-estimates-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417126\" data-ts=\"1544797639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417126-analysts-positive-on-starbucks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts positive on Starbucks</a></h4><ul> <li>Analysts are pushing up price targets on Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) even as traders bid the stock down in the premarket session.</li> <li>BMO Capital Markets increases its price target on SBUX to $63 from $58 and points to long-term potential, while Wells Fargo ($73 PT) and RBC Capital ($74 PT) are also positive on the coffee store chain. All three firms hiked their FY20 estimates on Starbucks.</li> <li>Starbucks' investor day presentation was largely seen as positive, with the exception being some reeled in expectations for China.</li> <li>Starbucks is <font color=\"red\">down 3.12%</font> in premarket trading to $64.81 after running up a 22% gain in the last 90 days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417126\" data-linked=\"Analysts positive on Starbucks\" data-tweet=\"$SBUX - Analysts positive on Starbucks https://seekingalpha.com/news/3417126-analysts-positive-on-starbucks?source=tweet\" data-url=\"https://seekingalpha.com/news/3417126-analysts-positive-on-starbucks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417125\" data-ts=\"1544797512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYT\" target=\"_blank\">NYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417125-nytplus-1_7-evercore-sees-low-valuation-promising-environment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYT +1.7% as Evercore sees low valuation, promising environment</a></h4><ul>   <li>New York Times Co. (NYSE:<a href='https://seekingalpha.com/symbol/NYT' title='New York Times Co.'>NYT</a>) is <font color=\"green\">up 1.7%</font> premarket after Evercore starts it at Outperform on growth prospects.</li>    <li>Eight years into a push for digital subscriptions to make up for a waning print advertising business, NYT is seeing \"a newfound willingness among young readers to pay for news.\" The news landscape (\"volatile and captivating\") presents an opportunity for NYT just as the company transitions from a print-ad reliance into a scaling digital subscriber base. (h/t Bloomberg)</li>    <li>The firm has a $32 price target, implying 28% upside.</li>    <li>Shares are <font color=\"green\">up 38.8%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417125\" data-linked=\"NYT +1.7% as Evercore sees low valuation, promising environment\" data-tweet=\"$NYT - NYT +1.7% as Evercore sees low valuation, promising environment https://seekingalpha.com/news/3417125-nytplus-1_7-evercore-sees-low-valuation-promising-environment?source=tweet\" data-url=\"https://seekingalpha.com/news/3417125-nytplus-1_7-evercore-sees-low-valuation-promising-environment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417124\" data-ts=\"1544797403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALQA\" target=\"_blank\">ALQA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417124-alliqua-biomedical-up-43-premarket-on-nida-funding-for-brivoligide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliqua Biomedical up 43% premarket on NIDA funding for brivoligide</a></h4><ul><li>Ultra-thinly traded nano cap Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) is up <font color=\"green\">43%</font> premarket on robust volume in apparent response to an <a href=\"https://www.sec.gov/Archives/edgar/data/1054274/000114420418064497/tv509094_ex99-1.htm\" target=\"_blank\">Award </a>from the National Institute on Drug Abuse &#40;NIDA&#41; to <a href=\"https://www.prnewswire.com/news-releases/alliqua-biomedical-inc-and-adynxx-inc-announce-merger-agreement-to-create-nasdaq-listed-clinical-stage-pharmaceutical-company-with-a-focus-on-pain-and-inflammation-300729959.html\" target=\"_blank\">merger partner</a> Adynxx to support the development of lead drug brivoligide for postoperative pain.</li><li>NIDA has agreed to provide $5.7M in funding over two years to facilitate the completion of a Phase 2 study in patients undergoing mastectomy (breast removal) with immediate tissue expander or implant replacement. Adynxx may receive an additional three-year award to support a Phase 3 trial.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417124\" data-linked=\"Alliqua Biomedical up 43% premarket on NIDA funding for brivoligide\" data-tweet=\"$ALQA $ADYX - Alliqua Biomedical up 43% premarket on NIDA funding for brivoligide https://seekingalpha.com/news/3417124-alliqua-biomedical-up-43-premarket-on-nida-funding-for-brivoligide?source=tweet\" data-url=\"https://seekingalpha.com/news/3417124-alliqua-biomedical-up-43-premarket-on-nida-funding-for-brivoligide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417122\" data-ts=\"1544797133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BEL\" target=\"_blank\">BEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417122-bel-and-wpm-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BEL and WPM among premarket gainers</a></h4><ul><li>Belmond (NYSE:<a href='https://seekingalpha.com/symbol/BEL' title='Belmond Ltd.'>BEL</a>) <font color=\"green\">+40%</font> after being <a href=\"https://seekingalpha.com/news/3417016-lvmh-buy-hotel-group-belmond-3_2b\" target=\"_blank\">acquired</a> by LVMH for $3.2B.</li><li>Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) <font color=\"green\">+39%</font>.</li><li>Tel-Instrument Electronics (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIK' title='Tel-Instrument Electronics Corp'>TIK</a>) <font color=\"green\">+23%</font> on <a href=\"https://seekingalpha.com/news/3417033-tel-instrument-electronics-announces-615k-international-order-tminus-47-m5-mode-5-test-set\" target=\"_blank\">announcing</a> $615K order for the T-47/M5 mode 5 test set.</li><li>Wheaton Precious Metals (NYSE:<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a>) <font color=\"green\">+15%</font> after <a href=\"https://seekingalpha.com/news/3417082-wheaton-precious-metals-plus-11-percent-settling-tax-dispute-cra\" target=\"_blank\">settling</a> tax dispute with CRA.</li><li>iKang Healthcare Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KANG' title='iKang Healthcare Group, Inc.'>KANG</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/pr/17358474-ikang-enters-amendment-3-merger-agreement-going-private-transaction\" target=\"_blank\">amending</a> its previous merger agreement.</li><li>XPO Logistics (NYSEMKT:<a href='https://seekingalpha.com/symbol/XPO' title='XPO Logistics, Inc'>XPO</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3417031-xpo-logistics-announces-share-repurchase-authorization-shares-7-percent-premarket\" target=\"_blank\">announcing</a> share repurchase authorization.</li><li>MYOS RENS Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a>) <font color=\"green\">+7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417122\" data-linked=\"BEL and WPM among premarket gainers\" data-tweet=\"$BEL $BEL $ADYX - BEL and WPM among premarket gainers https://seekingalpha.com/news/3417122-bel-and-wpm-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3417122-bel-and-wpm-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417121\" data-ts=\"1544797018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417121-schwab-new-brokerage-accounts-slide-14-m-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schwab new brokerage accounts slide 14% M/M</a></h4><ul><li>Charles Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>) <a href=\"https://seekingalpha.com/news/3409548-schwab-october-new-brokerage-accounts-rise-12-percent-m-m\" target=\"_blank\">new brokerage accounts </a>of 115,000 in November fell 14% from 133,000 in October.</li><li>Schwab <font color=\"red\">falls 1.0%</font> in premarket trading.</li><li>Core net new assets brought to the company by new and existing clients in November totaled $15.6B, up 5% from $14.9B in October.</li><li>Total client assets of $3.43T at Nov. 30, 2018 rose 1% M/M and 3% Y/Y.</li><li>Average interest-earning assets of $265.6B in November, up 1% M/M and 19% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3409548-schwab-october-new-brokerage-accounts-rise-12-percent-m-m\" target=\"_blank\">Schwab October new brokerage accounts rise 12% M/M</a> (Nov. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417121\" data-linked=\"Schwab new brokerage accounts slide 14% M/M\" data-tweet=\"$SCHW - Schwab new brokerage accounts slide 14% M/M https://seekingalpha.com/news/3417121-schwab-new-brokerage-accounts-slide-14-m-m?source=tweet\" data-url=\"https://seekingalpha.com/news/3417121-schwab-new-brokerage-accounts-slide-14-m-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417119\" data-ts=\"1544797009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417119-nucorminus-1_6-after-seeing-q4-earnings-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor -1.6% after seeing Q4 earnings below consensus</a></h4><ul><li>Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>) <font color=\"red\">-1.6%</font> pre-market after issuing <a href=\"https://seekingalpha.com/pr/17358710-nucor-announces-guidance-fourth-quarter-full-year-2018-results-including-record-annual\" target=\"_blank\">below-consensus guidance for Q4 EPS</a> of $1.90-$1.95 vs. $1.99 analyst consensus estimate; EPS was $2.13 in Q3 and $1.20 in the year-ago quarter.</li><li>For FY 2018, NUE expects EPS of $7.25-$7.30, which the company says would be a new annual record and a 22% increase over the previous EPS record of $5.98 in 2008.</li><li>President and CEO John Ferriola says NUE \"continue(s) to see strong demand and higher year over year average prices across most products\" entering 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417119\" data-linked=\"Nucor -1.6% after seeing Q4 earnings below consensus\" data-tweet=\"$NUE - Nucor -1.6% after seeing Q4 earnings below consensus https://seekingalpha.com/news/3417119-nucorminus-1_6-after-seeing-q4-earnings-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3417119-nucorminus-1_6-after-seeing-q4-earnings-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417118\" data-ts=\"1544796691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417118-shop-and-dtea-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SHOP and DTEA among premarket losers</a></h4><ul><li>DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a>) <font color=\"red\">-24%</font> on <a href=\"https://seekingalpha.com/news/3416967-davids-tea-reports-q3-results\" target=\"_blank\">Q3 earnings</a>.</li><li>Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-9%</font>.</li><li>Boxlight (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a>) <font color=\"red\">-8%</font>.</li><li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3416969-shopify-minus-3-percent-share-offering\" target=\"_blank\">share offering</a>.</li><li>Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3417024-axovant-sciences-readies-stock-offering\" target=\"_blank\">announcing</a> stock offering.</li><li>Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) <font color=\"red\">-6%</font>.</li><li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"red\">-6%</font>.</li><li>Harmony Gold Mining (NYSE:<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a>) <font color=\"red\">-5%</font>.</li><li>Uxin Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417118\" data-linked=\"SHOP and DTEA among premarket losers\" data-tweet=\"$DTEA $DTEA $ADIL - SHOP and DTEA among premarket losers https://seekingalpha.com/news/3417118-shop-and-dtea-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3417118-shop-and-dtea-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417117\" data-ts=\"1544796686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXON\" target=\"_blank\">AXON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417117-axovant-prices-stock-offering-1-shares-down-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant prices stock offering at $1; shares down 5% premarket</a></h4><ul><li>Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) is down <font color=\"red\">5% </font>premarket on modest volume in reaction to its <a href=\"https://seekingalpha.com/pr/17358768-axovant-sciences-announces-pricing-30-million-public-offering-common-shares\" target=\"_blank\">public offering</a> of 30M common shares at $1 per share. Underwriters over-allotment is an additional 4.5M shares. Closing date is December 18.</li><li>Yesterday's close was $1.13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417117\" data-linked=\"Axovant prices stock offering at $1; shares down 5% premarket\" data-tweet=\"$AXON $AXON-OLD - Axovant prices stock offering at $1; shares down 5% premarket https://seekingalpha.com/news/3417117-axovant-prices-stock-offering-1-shares-down-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3417117-axovant-prices-stock-offering-1-shares-down-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417113\" data-ts=\"1544796132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417113-davidsteaminus-19-after-earnings-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DavidsTea -19% after earnings disappoint</a></h4><ul> <li>DavidsTea (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a>) plunges in premarket trading after the company's Q3 report disappoints.</li> <li>Comparable sales were down 4.7% during the quarter after the company pulled back on discounting. Gross profit as a percentage of sales fell 60 bps to 42.1%.</li> <li>Shares of DavidsTea are <font color=\"red\">down 19%</font> to $1.62 (52-week low) to effectively wash out the rally of the last week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417113\" data-linked=\"DavidsTea -19% after earnings disappoint\" data-tweet=\"$DTEA - DavidsTea -19% after earnings disappoint https://seekingalpha.com/news/3417113-davidsteaminus-19-after-earnings-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3417113-davidsteaminus-19-after-earnings-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417112\" data-ts=\"1544796118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417112-bausch-health-nearly-150-upside-h-c-wainwright\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bausch Health has nearly 150% upside - H.C Wainwright</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>\"Headwinds Abating; Debt Seems Manageable; Synergy Bid Intrigues,\" goes the title of a note from H.C. Wainwright, upgrading the former Valeant to Buy, with price target lifted to $58 from $25 - that's well more than double yesterday's closing price.</li><li><a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"green\">+2.3%</font> premarket to $24.20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417112\" data-linked=\"Bausch Health has nearly 150% upside - H.C Wainwright\" data-tweet=\"$BHC - Bausch Health has nearly 150% upside - H.C Wainwright https://seekingalpha.com/news/3417112-bausch-health-nearly-150-upside-h-c-wainwright?source=tweet\" data-url=\"https://seekingalpha.com/news/3417112-bausch-health-nearly-150-upside-h-c-wainwright\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417111\" data-ts=\"1544796114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SN\" target=\"_blank\">SN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417111-sanchez-energy-borrowing-base-cut-to-315m-from-380m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanchez Energy borrowing base cut to $315M from $380M</a></h4><ul><li>Sanchez Energy (NYSE:<a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a>) <font color=\"red\">-2.5%</font> pre-market after disclosing its <a href=\"https://www.sec.gov/Archives/edgar/data/1528837/000110465918072851/a18-41526_18k.htm\" target=\"_blank\">borrowing base has been decreased</a> to $315M from $380M as part of the scheduled semi-annual redetermination.</li><li>SN said <a href=\"https://seekingalpha.com/news/3414523-sanchez-energy-hires-advisor-explore-strategic-alternatives\" target=\"_blank\">last week</a> it had retained an advisor to explore strategic alternatives, citing \"operational challenges, combined with volatility in the commodity markets and the company\u2019s leverage.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3417111\" data-linked=\"Sanchez Energy borrowing base cut to $315M from $380M\" data-tweet=\"$SN $SNEC - Sanchez Energy borrowing base cut to $315M from $380M https://seekingalpha.com/news/3417111-sanchez-energy-borrowing-base-cut-to-315m-from-380m?source=tweet\" data-url=\"https://seekingalpha.com/news/3417111-sanchez-energy-borrowing-base-cut-to-315m-from-380m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417106\" data-ts=\"1544795896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417106-infosys-joins-japan-jv-hitachi-panasonic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infosys joins Japan JV with Hitachi, Panasonic</a></h4><ul><li>Infosys (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>) <a href=\"https://asia.nikkei.com/Business/Markets/Infosys-forms-venture-in-Japan-with-Hitachi-others\" target=\"_blank\">forms a JV</a> with Hitachi, Panasonic, and Pasona to create a digital procurements platform.</li><li>As part of the deal, Infosys will buy an 81% stake in Hitachi's Procurement Service unit, which handles material purchasing functions. The other companies will be minority shareholders.</li><li>Infosys will bring its consulting, analytics, and digital tech knowledge to the venture. Hitachi and Panasonic will add procurement capabilities and the local team, bolstered by staffing firm Pasona.</li><li>Financial terms of the deal weren't disclosed.</li><li>Infosys shares are <font color=\"green\">up 1.4%</font> premarket to $10.01.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417106\" data-linked=\"Infosys joins Japan JV with Hitachi, Panasonic\" data-tweet=\"$INFY - Infosys joins Japan JV with Hitachi, Panasonic https://seekingalpha.com/news/3417106-infosys-joins-japan-jv-hitachi-panasonic?source=tweet\" data-url=\"https://seekingalpha.com/news/3417106-infosys-joins-japan-jv-hitachi-panasonic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417104\" data-ts=\"1544795705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417104-eaminus-4_1-bullish-needham-takes-knife-to-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EA -4.1% as bullish Needham takes knife to price target</a></h4><ul>   <li>Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) is <font color=\"red\">down 4.1%</font> premarket after Needham slashes its price target, pointing to a weaker release slate in 2020 than in 2019.</li>    <li>The firm cut its target to $100 from $150, cutting implied upside to a still healthy 23.7%.</li>    <li>The company is facing \"meaningfully lower\" margins on its upcoming <i>Star Wars</i> shooter than on this year's <i>Battlefield V,</i> due mainly to the license fee it pays Disney, the firm says. And \"In-game and FIFA Ultimate Team monetization have been weak this year, which we now expect to continue in FY20.\" (h/t Bloomberg)</li>    <li>EA's pipeline has been a key focus for analysts lately -- with Piper Jaffray <a href=\"https://seekingalpha.com/news/3415717-piper-shaves-optimism-ea-tough-year-ahead\" target=\"_blank\">pointing to a tough year ahead</a> that could make 2020 see easier comps, and Oppenheimer <a href=\"https://seekingalpha.com/news/3416810-oppenheimer-reassured-ea-pipeline-cfo-meeting\" target=\"_blank\">feeling better about the slate</a> after talking with management.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417104\" data-linked=\"EA -4.1% as bullish Needham takes knife to price target\" data-tweet=\"$EA - EA -4.1% as bullish Needham takes knife to price target https://seekingalpha.com/news/3417104-eaminus-4_1-bullish-needham-takes-knife-to-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3417104-eaminus-4_1-bullish-needham-takes-knife-to-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417101\" data-ts=\"1544795300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMED\" target=\"_blank\">AMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417101-goldman-bearish-on-walgreens-boots-alliance-in-premarket-analyst-action-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman bearish on Walgreens Boots Alliance in premarket analyst action; shares down 4% premarket</a></h4><ul><li>Amedisys (NASDAQ:<a href='https://seekingalpha.com/symbol/AMED' title='AMEDISYS Inc'>AMED</a>) initiated with Equal Weight rating and $130 (flat) price target at Barclays.</li><li>American Renal Associates (NYSE:<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings'>ARA</a>) initiated with Equal Weight rating and $18 (15% upside) price target at Barclays.</li><li>DaVita (NYSE:<a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a>) initiated with Overweight rating and $70 (18% upside) price target at Barclays.</li><li>Encompass Health (NYSE:<a href='https://seekingalpha.com/symbol/EHC' title='Encompass Health Corporation'>EHC</a>) initiated with Equal Weight rating and $75 (4% upside) price target at Barclays.</li><li>AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>) initiated with Buy rating and $48 (22% upside) price target at SunTrust.</li><li>Charles River Laboratories (NYSE:<a href='https://seekingalpha.com/symbol/CRL' title='Charles River Laboratories International, Inc.'>CRL</a>) initiated with Buy rating at Deutsche Bank.</li><li>Icon Public Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/ICLR' title='Icon PLC'>ICLR</a>) initiated with Hold rating at Deutsche Bank</li><li>IQVIA (NYSE:<a href='https://seekingalpha.com/symbol/IQV' title='IQVIA Holdings, Inc.'>IQV</a>) initiated with Buy rating at Deutsche Bank.</li><li>BioMarin Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a>) initiated with Neutral rating and $92 (2% downside risk) price target at Oppenheimer.</li><li>GlaxoSmithKline (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a>) initiated with Hold rating and $38 (flat) price target at SunTrust.</li><li>WellCare Health Plans (NYSE:<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a>) added to Conviction Buy List at Goldman Sachs. Price target remains at $323 (32% upside).</li><li>Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) upgraded to Buy with a $472 (25% upside) price target at Goldman citing its pipeline prospects and upside with Dupixent. Shares up a fraction premarket.</li><li>Bausch Health Companies (NYSE:<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a>) upgraded to Buy with a $58 (145% upside) price target at H.C. Wainwright. Shares up <font color=\"green\">2%</font> premarket.</li><li>Amneal Pharmaceuticals (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) downgraded to Equal Weight with an $18 (10% upside) price target at Morgan Stanley citing lack of near-term catalysts.</li><li>Universal Health Services (NYSE:<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a>) downgraded to Sell with a $125 (5% downside risk) at Goldman.</li><li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) downgraded to Sell with a $68 (17% downside risk) at Goldman citing deterioration in its retail pharmacy business. Shares down <font color=\"red\">4% </font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417101\" data-linked=\"Goldman bearish on Walgreens Boots Alliance in premarket analyst action; shares down 4% premarket\" data-tweet=\"$AMED $AMED $ARA - Goldman bearish on Walgreens Boots Alliance in premarket analyst action; shares down 4% premarket https://seekingalpha.com/news/3417101-goldman-bearish-on-walgreens-boots-alliance-in-premarket-analyst-action-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3417101-goldman-bearish-on-walgreens-boots-alliance-in-premarket-analyst-action-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417087\" data-ts=\"1544793844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417087-costcominus-4-on-margin-anxiety\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco -4% on margin anxiety</a></h4><ul> <li>Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) swings lower in premarket action after investors punish the retailer for missing consensus EPS estimates by just a penny.</li> <li>Analysts think that the focus is on the growing margin pressures at Costco and a slight miss with membership fee income during Q3.</li> <li>During Costco's earnings call, management was questioned on the margin outlook. \"We\u2019ve seen a little bit more margin pressure as there\u2019s been a little bit more retail competitive pressure out there, not only from supermarkets but Sam\u2019s as well,\" noted Costco CFO Richard Galanti (<a href=\"https://seekingalpha.com/article/4228258-costco-wholesale-corporation-cost-ceo-richard-galanti-q1-2019-results-earnings-call\" target=\"_blank\">conference call transcript</a>).</li> <li>COST <font color=\"red\">-4.37%</font> premarket to $216.61.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3417087\" data-linked=\"Costco -4% on margin anxiety\" data-tweet=\"$COST - Costco -4% on margin anxiety https://seekingalpha.com/news/3417087-costcominus-4-on-margin-anxiety?source=tweet\" data-url=\"https://seekingalpha.com/news/3417087-costcominus-4-on-margin-anxiety\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417086\" data-ts=\"1544793763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417086-loop-steps-to-hold-on-ciena\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loop steps to Hold on Ciena</a></h4><ul><li>Loop Capital downgrades Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) from Buy to Hold and reiterates the $36 price target.</li><li>Analyst James Kisner cites valuation.</li><li>Source: StreetAccount.</li><li>Ciena shares are<font color=\"red\"> down 1.6%</font> premarket to $34.34.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417086\" data-linked=\"Loop steps to Hold on Ciena\" data-tweet=\"$CIEN - Loop steps to Hold on Ciena https://seekingalpha.com/news/3417086-loop-steps-to-hold-on-ciena?source=tweet\" data-url=\"https://seekingalpha.com/news/3417086-loop-steps-to-hold-on-ciena\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417082\" data-ts=\"1544793358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417082-wheaton-precious-metalsplus-11-after-settling-tax-dispute-cra\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wheaton Precious Metals +11% after settling tax dispute with CRA</a></h4><ul><li>Wheaton Precious Metals (NYSE:<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a>) <font color=\"green\">+10.8%</font> pre-market on news it <a href=\"https://seekingalpha.com/pr/17358364-wheaton-precious-metals-reaches-settlement-canadian-tax-dispute-regarding-foreign-income\" target=\"_blank\">reached a settlement</a> with the Canada Revenue Agency over transfer pricing, which it says \"removes uncertainty with the use of our business model going forward and puts the tax issue behind us.\"</li><li>The settlement resolves WPM\u2019s tax appeal in  connection with the reassessment under transfer pricing rules of the  2005-10 taxation years related to income generated by the  company\u2019s wholly-owned foreign subsidiaries outside of Canada.</li><li>WPM says it does not anticipate any additional cash taxes will arise from the 2005-10 taxation years as a result of the  settlement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417082\" data-linked=\"Wheaton Precious Metals +11% after settling tax dispute with CRA\" data-tweet=\"$WPM - Wheaton Precious Metals +11% after settling tax dispute with CRA https://seekingalpha.com/news/3417082-wheaton-precious-metalsplus-11-after-settling-tax-dispute-cra?source=tweet\" data-url=\"https://seekingalpha.com/news/3417082-wheaton-precious-metalsplus-11-after-settling-tax-dispute-cra\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417066\" data-ts=\"1544791829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDRA\" target=\"_blank\">IDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417066-idera-pharma-down-11-premarket-on-updated-mid-stage-tilsotolimod-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idera Pharma down 11% premarket on updated mid-stage tilsotolimod data</a></h4><ul><li>Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) is down <font color=\"red\">11%</font> premarket on light volume following its release of <a href=\"https://seekingalpha.com/pr/17358516-idera-pharmaceuticals-presents-clinical-safety-efficacy-update-illuminateminus-204-trial\" target=\"_blank\">updated results</a> from the Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02644967?titles=illuminate-204&amp;lead=idera&amp;phase=1&amp;rank=1\" target=\"_blank\">ILLUMINATE-204</a> study evaluating tilsotolimod plus Bristol-Myers Squibb's (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) Yervoy (ipilimumab) in advanced melanoma patients who failed to respond to PD-1 inhibitor therapy [Merck's (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) Keytruda (pembrolizumab)].</li><li>34 patients were evaluable for efficacy and 37 for safety. The overall response rate &#40;ORR&#41; was 32% (n=11/34), including two complete responders. Using RECIST v1.1 criteria, the ORR was 29%. The disease control rate (responders + stable cancer) was 76% (n=26/34).</li><li>No new safety signals were observed.</li><li>In October, the company reported an ORR of 39% (n=8/21 which is actually 38%) which was consistent with the results reported in June.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3398924-idera-presents-new-data-tilsotolimod-investors-unmoved-shares-8-percent\" target=\"_blank\">Idera presents new data on tilsotolimod; investors unmoved, shares down 8%</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3417066\" data-linked=\"Idera Pharma down 11% premarket on updated mid-stage tilsotolimod data\" data-tweet=\"$IDRA $IDRA $BMY - Idera Pharma down 11% premarket on updated mid-stage tilsotolimod data https://seekingalpha.com/news/3417066-idera-pharma-down-11-premarket-on-updated-mid-stage-tilsotolimod-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3417066-idera-pharma-down-11-premarket-on-updated-mid-stage-tilsotolimod-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417065\" data-ts=\"1544791803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417065-recode-facebook-wants-in-on-pay-tv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recode: Facebook wants in on pay TV</a></h4><ul><li>Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>)<a href=\"https://www.recode.net/2018/12/13/18139946/facebook-hbo-pay-tv\" target=\"_blank\"> wants to enter</a> the pay TV business by selling subscriptions to cable networks like HBO and Showtime, which users could watch through Facebook's apps.</li><li>Amazon already has a similar model in place, and Apple's answer is expected to arrive next year.</li><li>Recode sources say Facebook's media team has held talks with cable networks for months and would like to launch the product in 1H19.</li><li>Facebook shares are <font color=\"red\">down 1%</font> premarket to $143.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417065\" data-linked=\"Recode: Facebook wants in on pay TV\" data-tweet=\"$FB - Recode: Facebook wants in on pay TV https://seekingalpha.com/news/3417065-recode-facebook-wants-in-on-pay-tv?source=tweet\" data-url=\"https://seekingalpha.com/news/3417065-recode-facebook-wants-in-on-pay-tv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417060\" data-ts=\"1544791411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417060-nvidia-amd-get-target-trims-on-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia, AMD get target trims on pricing</a></h4><ul><li>Mizuho analyst Vijay Rakesh trims his Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) and AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) targets but keeps both at a Buy rating.</li><li>Rakesh sees the first signs of price stabilization since the cryptocurrency mining-related peak earlier this year, but the prices aren't rising quickly.</li><li>The analyst slightly lowers his 2019 view on AMD's earnings and revenue but has a better outlook for 2020 as new product launches serve as a tailwind.</li><li>Nvidia's target drops from $245 to $230. AMD drops from $33 to $30.</li><li>Source: Bloomberg First Word.</li><li>NVDA is <font color=\"red\">down 1%</font> premarket and AMD is <font color=\"red\">down 1.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417060\" data-linked=\"Nvidia, AMD get target trims on pricing\" data-tweet=\"$NVDA $NVDA $AMD - Nvidia, AMD get target trims on pricing https://seekingalpha.com/news/3417060-nvidia-amd-get-target-trims-on-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3417060-nvidia-amd-get-target-trims-on-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417056\" data-ts=\"1544790838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417056-ciscominus-2-nomura-goes-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco -2% as Nomura goes to sidelines</a></h4><ul><li>Nomura downgrades Cisco Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) from Buy to Neutral with a $50 price target.</li><li>Analyst Jeffrey Kvaal: \"We believe some tailwinds, notably IT spending strength, may reverse in 2019 to reveal imperfections in Cisco\u2019s story.\"</li><li>Kvaal lowers his 2020 earnings estimate to $3.25 a share from $3.00.</li><li>Source: Bloomberg First Word.</li><li>Cisco shares are <font color=\"red\">down 2.2%</font> premarket to $46.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417056\" data-linked=\"Cisco -2% as Nomura goes to sidelines\" data-tweet=\"$CSCO - Cisco -2% as Nomura goes to sidelines https://seekingalpha.com/news/3417056-ciscominus-2-nomura-goes-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3417056-ciscominus-2-nomura-goes-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417051\" data-ts=\"1544789963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417051-noted-analyst-cuts-iphone-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noted analyst cuts iPhone estimates</a></h4><ul><li>Noted Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) analyst Ming-Chi Kuo <a href=\"https://www.cnbc.com/2018/12/14/top-apple-analyst-kuo-slashes-apple-iphone-shipment-estimates-by-20percent.html\" target=\"_blank\">cuts</a> his Q1 iPhone shipment estimates by 20% to between 38M and 42M. Kuo expects 205M to 210M shipments in 2018 and a 5% to 10% drop in 2019 to 188M to 194M.</li><li>The current 2019 consensus is 212M iPhones shipments.</li><li>Kuo cites lower demand for the newer models, particularly the low-cost XR, which legacy models can't offset.</li><li>Apple shares are <font color=\"red\">down 1%</font> premarket to $169.20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417051\" data-linked=\"Noted analyst cuts iPhone estimates\" data-tweet=\"$AAPL - Noted analyst cuts iPhone estimates https://seekingalpha.com/news/3417051-noted-analyst-cuts-iphone-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3417051-noted-analyst-cuts-iphone-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>97&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417050\" data-ts=\"1544789819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELAN\" target=\"_blank\">ELAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417050-elanco-animal-health-to-restructure-37m-charge-this-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elanco Animal Health to restructure, $37M charge this quarter</a></h4><ul><li>Citing the need to shift its focus and resources to priority areas, Elanco Animal Health (NYSE:<a href='https://seekingalpha.com/symbol/ELAN' title='Elanco'>ELAN</a>) will implement a year-long <a href=\"https://www.sec.gov/Archives/edgar/data/1739104/000110465918072854/a18-41534_18k.htm\" target=\"_blank\">restructuring plan</a> that will include job cuts. It will record a $37M charge this quarter, comprised of $19M in severance costs and $18M in asset write-offs. Total cash costs should be ~$20M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417050\" data-linked=\"Elanco Animal Health to restructure, $37M charge this quarter\" data-tweet=\"$ELAN - Elanco Animal Health to restructure, $37M charge this quarter https://seekingalpha.com/news/3417050-elanco-animal-health-to-restructure-37m-charge-this-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3417050-elanco-animal-health-to-restructure-37m-charge-this-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3417046\" data-ts=\"1544789287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3417046-merck-to-acquire-antelliq-group-for-2_1b-plus-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merck to acquire Antelliq Group for \u20ac2.1B plus debt</a></h4><ul><li>Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) has agreed to <a href=\"https://seekingalpha.com/pr/17358488-merck-acquire-privately-held-antelliq-group\" target=\"_blank\">acquire </a>all of the outstanding shares of animal health outfit <a href=\"https://www.antelliq.com/\" target=\"_blank\">Antelliq Group</a> for \u20ac2.1B in cash plus the assumption of \u20ac1.15B in debt.</li><li>Privately held Antelliq provides digital animal identification, traceability and monitoring solutions. It generated sales of \u20ac360M during the 12-month period ending September 30.</li><li>The transaction should close in Q2 2019.</li><li>Shares are down <font color=\"red\">2%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3417046\" data-linked=\"Merck to acquire Antelliq Group for \u20ac2.1B plus debt\" data-tweet=\"$MRK - Merck to acquire Antelliq Group for \u20ac2.1B plus debt https://seekingalpha.com/news/3417046-merck-to-acquire-antelliq-group-for-2_1b-plus-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3417046-merck-to-acquire-antelliq-group-for-2_1b-plus-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}